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Schistosomiasis, caused by the schistosomes, is a life threatening infection of 
humans in many tropical areas and developing countries. In China, schistosomiasis is 
a major public health problem. The disease is caused by three main species: 
Schistosoma haematobium. Schistosoma mansoni and Schistosoma japonicum. 
In human, the skin has a prominent role in the innate immunity and can respond 
immunologically within minutes, but the penetration of schistosomes of Schistosoma 
mansoni does not evade any inflammatory response. Previous studies (Ramaswamy et 
al.’ 1995 & Ramaswamy et al, 1996) showed that the excretory/secretory (ES) 
products of the schistosomes of Schistosoma mansoni can down-regulate the 
production of pro-inflammatory cytokines interleukin-la (IL-la) and IL-1(3 in human 
keratinocytes, simultaneously, with a significant increase in the production of the 
anti-inflammatory cytokine IL-lra. An anti-inflammatory protein in the ES product 
was subsequently identified and named as Sml6. The gene encoding Sml6 was also 
cloned and partially characterized (Rao & Ramaswamy, 2000). 
At present, there is limited knowledge on the mechanisms of immune evasion by 
schistosomes. In this project, the gene encoding for the anti-inflammatory protein 
(Sjl6) of S. japonicum was cloned. Schistosoma japonicum mainly associates with the 
Schistosomiasis in Asia. Sjl6 of S. japonicum is a homologue of Sml6 of 5. mansoni. 
For cloning, pBluescript II SK(-)/Sjl6 was constructed. For expression, 
pSecTag2B/Sjl6 and pET30a+/Sjl6 were constructed. Recombinant Sjl6 was 
successfully expressed in E.coli, then purified by affinity column and dialyzed in PBS. 
IV 
The recombinant Sjl6 in PBS was used for immunological function characterization. 
The immunological functions of Sjl6 were illustrated by its anti-inflammatory effect 
and immunosuppressive effect. 
The anti-inflammatory function of recombinant Sjl6 was proved by its inhibitory 
effect on thioglycollate induced inflammation in balb/c mice. The recombinant Sjl6 
suppresses the thioglycollate stimulated macrophage recruitment in balb/c peritoneal 
cavity. The immunosuppressive function of recombinant Sjl6 was demonstrated by its 
inhibitory effect on rMuIFN-a4 induced up-regulation of MHC (I) expression on JCS 
cell surface. Also, the recombinant Sj 16 is proved to be immunogenic and antigenic. 
Based on the results, further experiments may be done to analyze the interaction 
site of Sjl6 with its receptor. With the understanding of the molecular structures of 
Sjl6 and its receptor may pave a road for the discovery of an alternative method for 
anti-inflammatory therapy. Effective anti-inflammatory therapy is in urgent need as 
inflammation related diseases affect millions of patients over the world. Also, 
characterization of immunological function of Sjl6，provides cue for the 
understanding of the underlying host-parasite interacting mechanisms to discover how 
the anti-inflammatory protein interacts with the host to evade the immune system in 
Schistosoma sp.. In long term, this research provides valuable information for the 






Schistosoma haematobium, Schistosoma mansoni 禾口 Schistosoma japonicum� 
皮膚在人類免疫防禦機制中的擔當一個重要的角色，它可以在短短幾分鐘內 
產生免疫反應。但是’當曼氏血吸蟲(Schistosoma 的尾蝴鑽入人的皮 
膚時，卻不能引起強烈的炎症反應。據硏究（Hamaswamy et ai, 1995 & 
Ramaswamy etaL, 1996)顯示曼氏血吸蟲排泄分泌物中’有一種物質能抑制人類 
質細胞interleukin-la ( IL- la )及 IL- ip的表達。同時，產生大增量具抗發炎功 
效的 IL- l ra�一種分子量爲16.8kDa的抗發炎蛋白質在曼氏血吸蟲排泄分泌物 
中找到，並命名爲 S m l 6 � Sml6的基因序列及部份功能已被硏究（Rao & 




這個硏究中，Sjl6的免疫功能會被硏究。首先，被克隆入pBluescript II SK(-) 
載體中。爲表達Sjl6，Sjl6的基因再被克隆入pSecTag2B和pET30a+表達載體 
中。最後S j 16能成功地利用桿菌表達。表達物用affinity column純化和滲析 















Abbreviation used in the thesis without definition include: 
Abbreviations Full term 
AP Alkaline phosphatase 
ATP Adenosine triphosphate 
bp base pair 
cDNA complementary deoxyribonucleic acid 
DEPC Diethyl pyrocarbonate 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleoside triphosphates (dATP, 
dTTP, dGTP，dCTP) 
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme linked immunosorbent assay 
PACS Fluorescent-activated cell sorting 
PCS Fetal calf serum 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
IFN- Interferon- (e.g. Interferon-a, IFN-a) 
Ig Immunoglobin 
IL- Interleukin- (e.g. Interleukin-1, IL-1) 
IL-lra Interleukin-1 receptor antagonist 
IPTG Isopropyl-P-D-thiogalactopyranoside 
JCS WEHI 3B JCS 
kb kilo base — — 
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Abbreviations Full term 
kDa kilo Dalton 
LB medium Luria Bertani medium 
LPS Lipopolysaccharides 
MAP kinase Mitogen activated protein kinase 
M-CSF Macrophage colony stimulating factor 
MHC Major histocompatibility complex 
MW Molecular weight 
mRNA messenger ribonucleic acid 
OD Optical density 
p g r Polymerase chain reaction 
PBS Phosphate buffered saline, pH 7.4 
R]S[A Ribonucleic acid 
R j Reverse transcription 
ipm Revolutions per minute 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis 
jAE Tris-acetate-EDTA 
XGF- Transforming growth factor- (e.g. TGF-a) 
XNF_ Tumor necrosis factor- (e.g. TNF-a) 
丁ris Tris (hydroxymethyl) aminomethane 
UV Ultra violet 
w/v Weight by volume 
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Chapter One : Introduction 
1.1 The Schistosoma Species 
The Schistosoma species under the family Schistosomatidae are digenetic 
trematodes. Adult schistosomes share all the fundamental features of the digenea. 
They are unsegmented, dioecious worms which are oviparous. They bear 2 suckers 
with complex life cycle. Their life cycle is completed in the definitive hosts (e.g. 
humans) and intermediate hosts (e.g. freshwater snail). Schistosoma cause infections 
in vertebrates. Adult worms parasitize in mesenteric blood vessels in the host. Hence, 
they are known as blood flukes. The male is short and stout. It holds the relatively 
long female worm in its gynecophoric canal (a groovelike structure). Eggs are laid 
and passed through urine or feces to fresh water; free-swimming, fork-tailed larva in 
fresh water can infect a new host by penetrating the skin and travel through 
circulation. Then the larvae mature and develop into adult worms. The life cycle 
repeats (Rollinson and Southgate, 1987) 
Schistosoma species are divided into four groups based on the geographical 
distribution, morphology of the eggs and the genera of snail host (Table 1.1). 
Table 1.1 Classification of Schistosoma species. 
S. mansoni Group : intermediate hosts are snails of the genus Biomphalaria. Eggs are 
usually laterally spined. These parasites are restricted in Africa (except S. mansoni). 
S. mansoni Parasite of humans. 
S. rodhaini Parasite of rodents and carnivores. 
S. edwardiense Parasite of ruminants. 
1 
S. hippopotami Parasite of hippopotamus. 
S. haematobium Group : intermediate hosts are snails of the genus Bulinus. Eggs are 
usually terminally spined. These are parasites of Africa, the Mediterranean area and 
the Middle East. 
S. haematobium Parasite of humans. 
S. intercalatum Parasite of humans. 
S. bovis Parasite of cattle sheep and goats. Man rarely infected. 
S. mattheei Parasite of primates and ruminants. Man may get infected. 
S. curassoni Parasite of ruminants. 
S. margrebowiei Parasite of ruminants. 
S. leiperi Parasite of ruminants. 
S. japonicum Group : intermediate hosts are snails of the genera Oncomelania, 
Robertsiella and Tricula in East Asia. 
S. japonicum Parasite of humans and some other animals. 
S, mekongi Parasite of humans and some other animals. 
S. malayensis Parasite of humans (rarely) and some other animals. 
S. sinensum Parasite of rodents. 
S. indicum Group : intermediate hosts are snails of the genera Indoplanobis, Radix 
and Lymnacea in Asia. 
S. indium Parasite of ruminants. 
S. spindale Parasite of ruminants and dogs. 
S. nasale Parasite of ruminants. 
S. incognitum Parasite of rodents, carnivores and ruminants, 
(modified from Rollinson and Southgate, 1987) 
2 
1.1.1 The Schistosoma Gene Discovery 
The schistosome genome project was initiated by the World Health Organization 
(WHO) in 1994. The main objective of the project is to discover and characterize new 
genes in S. mansoni and S. japonicum', in order to search for new targets for drugs, 
vaccines, and diagnostic development through the information on chromosome maps, 
whole genome sequencing and genome analysis (Franco et al., 2000). Schistosoma 
carry a large genome, about 270Mb with 60% repetitive sequence which contained on 
8 pairs of chromosomes with 3 pairs of small sized, 3 pairs of medium sized and 2 
pairs of large sized (Short, 1983; Brindley et al., 2003; El-Sayed et al, 2004). Female 
schistosomes contain a ZW pair of chromosome, where the male schistosomes contain 
a ZZ pair (Simpson et al., 1982). It is expected the genome contains about 20,000 
genes (LoVerde et al., 2004). In S. mansoni, there are approximately 16,689 ESTs 
obtained from different developmental stages that deposited in the NCBI EST 
database (LoVerde et al., 2004). The analysis of S. japonicum gene expression profile 
is based on expressed sequence tags (Peng et al, 2003). Up-to-date, there are 45,902 
ESTs deposited in the NCBI EST database. The gains of knowledge of the 
schistosome genome provide information for the understanding of parasite biology; 
study of metabolic pathways for drug resistance; mechanisms of antigenic variations, 
molecular mimicry; and identify protein-protein interactions for escaping the host's 
immune system (Bickle and Oldridge, 1999; Hu et al, 2003; McManus et al, 2004a; 
Shrivastava et al, 2005). 
-> 
1.1.2 Schistosome Transcriptome 
The transcriptome is read from the data obtained from the expressed-sequence 
tags (EST). In S. japonicum, there are a total of 45,000 expressed-sequence tags 
derived from adult worms and eggs (Verjovski-Almeida et al, 2004). The 
transcriptome analysis provides understanding of the molecular mechanisms involved 
in evolution; nutrition and metabolism; host-dependent development and maturation; 
immune evasion and potential vaccine candidates (Verjovski-Almeida et al, 2003; Hu 
et al, 2004; McManus et al, 2004; Wilson et al, 2004). In details, the transcriptome 
analysis of mansoni suggests that there is an early divergence of the parasite from 
other metazoan by phylogenetic analysis. Also, the information on gene expression on 
different developmental stages and molecular mechanisms in biochemical systems 
identify novel proteins as vaccine candidates and potential drug targets 
(Verjovski-Almeida et al” 2003). 
1.2 Schistosomiasis 
Schistosomiasis is a TDR Category II Disease. TDR, the Special Programme for 
Research and Training in Tropical Diseases is an independent global programme of 
scientific collaboration. Category II means that control strategy for the disease is 
available, but disease burden persists; and researches are focuses on development and 
testing of new disease control and strategies (WHO, 1984). Schistosomes cause the 
most important human helminth infection, schistosomiasis worldwide and are 
considered by the World Health Organization (WHO) as second in importance only to 
malaria. Millions of people infected worldwide; especially in the developing countries, 
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for example, China, Africa, South America, the Middle East, India and the Philippines. 
There are five major species in Schistosoma that cause infections, schistosomiasis in 
humans worldwide : Schistosoma haematobium causes urinary schistosomiasis, 
Schistosoma mansoni and Schistosoma intercalatum cause intestinal schistosomiasis, 
Schistosoma japonicum and Schistosoma Mekongi cause Asian intestinal 
schistosomiasis. Schistosomiasis infection has a relatively low mortality rate, but a 
high morbidity rate, causing severe debilitating illness in millions of people. The 
disease is often associated with water resource development projects, such as dams 
and irrigation schemes, where the snail intermediate hosts of the parasite breed (Faust 
and Meleney, 1924). 
According to WHO, globally, about 120 million of the 200 million infected 
people are estimated to be symptomatic and 20 million are thought to suffer severe 
consequences of the infection. Annually an estimated 20,000 deaths are associated 
with the severe consequences of infection, including bladder cancer, renal failure, 
liver fibrosis and portal hypertension. Schistosomiasis is a public health problem, 
however, it is often not a priority for health authorities. Due to its non-specific signs 
and symptoms and its insidious nature, affected people often do not perceive 
schistosomiasis as a serious health problem, thus favoring the development of late, 
irreversible consequences, such as anemia, impaired growth and development 
(Stadecker et al, 2004). 
1.2.1 Immunopathology of Schistosomiasis 
The adult worms do not multiply in the host, the eggs deposited are the main 
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cause of pathology in schistosomiasis. The eggs deposited by the adult schistosomes 
penetrating the blood vessels and the host tissues by secreting proteolytic enzymes 
through ultramicroscopic pores in their shell. However, many eggs become stranded 
in the hepatic and tissues or are carried via the blood stream to other organs of the 
body (Bartlett et al, 2000). The host's immune response to the eggs may vary from 
forming small granulomas to extensive fibrosis. Adult S. mansoni reside in mesenteric 
veins and lay eggs there, the eggs trapped in microvasculature of liver caused 
vigorous granulomatous response (Rumbley et al, 1998; Wynn，2004; Stavitsky, 
2004). The eggs also accumulate in intestinal tissues that induce mucosal 
inflammation, lead to intestinal schistosomiasis (Chen, 1991; Stadecker et al, 2004). 
Cerebral schistosomiasis caused by the accumulation of parasite eggs in the host 
nervous system (Chen, 1991). For urinary schistosomiasis, it is due to damages in 
urinary tract revealed by blood in urine. 
Many infections are asymptomatic. Acute schistosomiasis may occur weeks after 
the initial infection, especially by S, mansoni and S. japonicum. Symptoms include 
fever, cough, abdominal pain, diarrhea, hyperplasia and granulomatous inflammation. 
Occasionally central nervous lesions occur. For chronic schistosomiasis, hepatic and 
periportal fibrosis, portal hypertension and protosystemic shunting of venous blood 
may occur (Pearce and MacDonald, 2002). Sufferers become seriously weakened by 
the disease, the functioning of organs such as spleen and kidneys become impaired 
(Yamashita et al, 1987). 
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1.2.2 Diagnosis of Schistosomiasis 
Schistosome antigens are present in the blood, urine, feces and other excreta of 
infected people. Antibodies based diagnostic methods can be applied. However, the 
most obvious method of diagnosis is the identification of eggs in the stool or urine 
and egg concentration technique is required. Also, rectal, liver or bladder biopsies 
may be required if no eggs are found (Bergquist，2002). 
1.2.3 Treatment and Control for Schistosomiasis 
Chemotherapy is the principal method for treating schistosomiasis, praziquantel 
is the drug of choice. Recently, artemether is being tested as a novel drug for treating 
schistosomiasis (Xiao et al, 2002). Praziquantel can reverse the pathology of the 
disease (Cioli and Pica-Mattoccia, 2003). However, if the extensive damages have 
occurred, the damages cannot be reversed and are permanent. Recently, it has been 
found that certain populations respond poorly to praziquantel treatment and 
praziquantel resistance strains have also been reported in S. mansoni (Ismail et al, 
1999; Liang et al., 2001). Other control methods have been applied. The methods are : 
drainage of marsh areas where snails breed, improve sanitation, education and the use 
of molluscicides. There are ample evidences from countries where schistosomiasis 
control was implemented, that the WHO recommended strategy for morbidity control 
is effective. Four national control programmes : Brazil, China, Egypt and the 
Philippines, demonstrated that control efforts together with economic development 
can decrease morbidity to low levels (WHO, 1984; Savioli et al., 1997). 
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Schistosomiasis is a major public health problem in China. It is endemic in areas 
of Yangtze River, Sichuan and Yunnan (He et al, 1994). In 1992, a large-scale 10 
years schistosomiasis control project has been carried out which supported by the 
World Bank Loan. The control strategy was focused on chemotherapy, the use of 
praziquantel; and complemented by health education, chemical control of snails. The 
project was very successful, the infection rates in humans and livestock had decreased 
by 55% and 50%, respectively (Chen et al., 2005). 
1.2.4 Vaccine Development for Schistosomiasis 
The use of vaccine, subunit or DNA vaccine to reduce parasite or egg is a 
valuable tool and has considerable advantages (Zhang et al, 1999; Zhu et al, 2005) 
over the use of chemotherapy. If a vaccine can available for long-term prevention, it is 
less costly and more practical (Wynn and Hoffmann, 2000; Chen et al, 2003; 
Solomon et al, 2004; Peng et al, 2004; Rao and Ramaswamy, 2000). 
Vaccination of mice with ultraviolet attenuated cercariae or y-irradiated cercariae 
can evoke protective immunity against a challenge infection. The identification of 
parasite antigens that can induce protective immune responses is currently being 
considered as vaccine candidates. It is suspected that the stage-specific expression of 
surface antigens can serve as potential vaccine target (Gobert, 1998; Vicogne et al, 
2004; Osada et al, 2005). 
WHO Schistosome Genome Programme helps to identify and characterize 
potential drug targets and vaccine candidates. Progress has been made in 
understanding of host-parasite relationships in schistosomiasis which will be central 
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to the development of effective vaccines and better drug. The transcriptome and 
proteomics also help to identify proteins that are important for parasite survival or 
secretory proteins as strong vaccine candidates (Li et al, 2000; Wilson et al, 2004; 
Solomon et al, 2004). 
A vaccine based on S. mansoni glutathione-S-transferase (Sm28 GST) is 
identified as a target antigen of the Th2 effector response in rats has entered phase I 
human clinical trail. Vaccination experiments performed using recombinant Sm28 
GST has demonstrated partial protective effect (Capron, 1998). Also, DNA vaccine of 
S. mansoni asparaginyl endopeptidase (Sm32) (Ruppel et al., 2002) and DNA vaccine 
of S. japonicum fatty acid binding protein (SjMFABP) (Liu et al, 2004) have 
shown a significant reduction in schistosome egg production in vaccinated mice. 
1.3 The Species, Schistosoma japonicum 
Schistosoma japonicum causing Schistosomiasis japonica was discovered and 
named by Katsurada in 1904 (Katsurada, 1904). The disease was first recorded in 
Katayama district in Japan (Fujii, 1847). The parasites S, japonicum is found in the 
Far East, China and the Philippines. In China, Schistosomiasis japonica is endemic 
along parts of the Yangtze River basin. S. japonicum causes intestinal schistosomiasis 
in humans is slow to develop. There is progressive enlargement of the liver and spleen, 
intestinal damage due to fibrotic lesions around eggs lodged in these tissues, and 
hypertension of the abdominal blood vessels. Bleeding from these vessels leads to 
blood in stools and can be fatal. Sufferers become seriously weakened by the disease 
and the functioning of organs such as spleen and kidneys becomes impaired. 
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1.3.1 The Life Cycle of Schistosoma japonicum 
Schistosoma japonicum has a complex life cycle which alternate between two 
hosts and with short-lived water-bom form. In S. japonicum, eggs are passed out from 
the feces of the infected people. The released eggs hatch in aggregations of water such 
as ponds and lakes under optimal conditions. The free-swimming miracidiae hatch 
from the egg into the water, where they infect the suitable intermediate snail hosts -
Oncomelania hupensis by penetrating through the host's surface. Inside the snail host, 
they go through two generations of asexual stage of sporocysts. The second sporocyst 
stage produces fork-tailed cercariae. Several thousands of cercariae can be produced 
from a single miracidium infection of an infected snail. After complete development, 
the cercariae migrate to the snail surface and shed into the environment. The 
free-swimming cercariae upon release from the snail, penetrate the skin of the 
definitive mammalian hosts by releasing proteases. Human is one of the definitive 
host of Schistosoma japonicum. Cercariae are attracted to the host by chemotaxis as 
the host body gives off skin oil and chemical signals, when the host comes into 
contact with the contaminated water. Once get penetrated into the skin, the cercariae 
shed their tails to become schistosomulae. The schistosomulae migrate through 
several tissues and stages until they reach the portal venous system of the liver. The 
male and female adult worms settle down in pairs in the superior mesenteric veins 
draining the small intestine, copulate and eggs are laid. The eggs move progressively 
and penetrate into the lumen of intestine and eliminated with the feces. The cycle 
repeats (Faust and Meleney, 1924; He et al, 2001; Ross et ^？/., 2001) (Fig. 1.1). 
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Fig. 1.1 The life cycle of Schistosoma japonicum (modified from Faust and Meleney, 
1924). 
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1.3.1.1 The Egg, Miracidium Phase of the Life Cycle 
The fertilized egg of S. japonicum is a lenticular, ovoid object, about 67 by 50 
l^ m in size, which formed in the uterus of the adult female worm and deposited in the 
wall of gut of the definitive hosts. The egg bears a pronounced spine on one side near 
the anterior end. The eggs then migrate from the gut through blood vessels to the 
feces, it is a complex process and numerous factors involved. The egg that found in 
the feces is an oval object about 89 by 66 jum. The eggs found in the infected hosts 
usually contain mature or nearly mature miracidium. The hatching of the eggs is 
affected by different internal and external factors : the maturity of the miracidium, 
increased internal tension, temperature and acidity. The miracidium escapes through a 
longitudinal split in the shell, usually opposite the spine. The mature miracidium is 
free-swimming, with epidermal cilia and the size is about 120 by 40 |Lim. The 
miracidium swims around in a typical fashion during a period of 60 to 72 hours, 
termed the infective stage. When the miracidium comes in contact with the specific 
mollusc host, it penetrates the intermediate host by head-on boring motion and aided 
by proteolytic substances secretion (Faust and Meleney, 1924). 
1.3.1.2 Developmental Cycle within Mollusc Host 
When the miracidium invaded the snail host, morphological changes takes place 
and goes through two generations of sporocysts stage. First, the primary mother 
sporocysts develop from miracidium within several days of invasion. During the 
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development, the miracidium loses its differential characteristics and elongates to 
about 25 by 100 and contained within the body cavity. The morula stage of the 
secondary sporocysts is developed inside the primary sporocysts. Later, the primary 
sporocysts ruptured, setting free the secondary sporocysts which contain the germ 
balls of the cercarial generation. Then, the cercariae differentiate with tail (Faust and 
Meleney, 1924). 
1.3.1.3 The Cercaria Phase of Life Cycle 
The cercaria is free-swimming and divided into body and tail, with the length of 
about 0.32 mm. The surface of cercaria is covered by a single continuous syucytial 
tegument of 0.5 |im thick. Glycocalyx of about 2 thick is covered on the syncytial 
tegument for protection. 
On reaching maturity within the parent sporocyst in the liver of the snail the 
cercaria erupts spontaneously and comes to lie in the surface film over the mouth of 
the snail. Movement of cercaria consists of four types : nervous, jerky motion; 
free-swimming movement; sinking movement; and measuring worm movement. The 
cercaria attracts to the host chemotactically and penetrates into the human skin. The 
actual penetration is a combined mechanical and secretory process. The penetration of 
host's skin is by secreting proteolytic enzymes, e.g. cercarial elastase secretion from 
the penetration glands (Rumjanek and McLaren, 1981; Angeli et al, 2001; Curwen 
and Wilson, 2003; McKerrow, 2003; Salter et al., 2002). As the penetration proceeds 
there are structural and physiological changes occur and accompany with the 
transformation of fork-tailed, free-swimming infective cercaria into parasitic larval 
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schistosomula. The tail of cercaria shed off through penetration. During migration, the 
tegumental surface protein expression is gradually decreased (Hirata et al., 2005). 
Then, the schistosomula gains access to the lymph and blood vessels. During the first 
24 hours, there is a remarkable turnover of surface molecules on the schistosomula 
surface, the glycocalyx layer is replaced by a new double membrane on the syncytial 
surface. As time passes there is the appearance of more surface molecules which have 
low reactivity in stimulating the host's immune system. By 24 to 48 hours the 
schistosomula has become completely refractory to antibody mediated cell 
cytotoxicity. In addition to providing molecules on the surface that mask antigenic 
epitopes, the schistosomula surface also has the ability to coat itself with host 
molecules (Faust and Meleney, 1924). 
After the transformation of cercaria into schistosomula in the host's skin, the 
schistosomula further penetrates the blood vessel and travels to the lungs through 
blood circulation. The schistosomula reaches the liver in the end, stays there to 
develop into sexually mature adult worms (Faust and Meleney, 1924). 
1.3.1.4 Adult Schistosome in Definitive Host 
All of the developmental stages of the parasite from the penetration of the 
cercaria to the sexual maturity of the worms in the portal system have a continuous 
series of 24 stages. The schistosomes are dioecious. The female are longer and 
matures more rapidly than the male. The female and male pair up in the liver, where 
they copulate and laid eggs to finish the life cycle (Faust and Meleney, 1924). The 
cycles then repeat after the eggs shed in the water body. 
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1.4 Invasion by Schistosome Cercariae 
Cercariae are excreted by the snail into water. They follow a thermal gradient to 
find their hosts and response chemotactically to the human skin chemicals, such as 
linoleic acid. The cercariae penetrate the human skin by the aid of the acetabular 
gland secretion (McKerrow and Salter, 2002; Whitifield et al, 2003; Ruppel et al, 
2004; He et al, 2005). 
The skin has a prominent role in human innate immunity and houses many 
immunological cells, such as keratinocytes, Langerhans cells, lymphocytes and mast 
cells that can respond immunologically within minutes after activation (Burbach et al, 
2001; O'Leary, 2002). During the process of penetration, cercariae lose their tail, and 
undergo a serious of biochemical, physiological and morphological changes to 
transform into schistosomulae. The schistosomulae are latent under the epidermis for 
about 48-72 hours after gaining entry into the skin before migrating further to other 
organs to complete their biological cycle as they make their way to the blood stream 
(Wright et al, 1991; Riengrojpitak et al, 1998; He et al, 2002; Malcolm et al, 2004; 
Wang et al, 2005). The delayed migration of the schistosomulae in the skin gives the 
opportunity for the host immune system to interact with the parasite. However, studies 
showed that low or moderate schistosoma infections do not elicit any inflammatory 
responses in the skin (Fusco et al, 1993; Fusco et al, 1993a; Mountford and Trottein, 
2004; Chlichlia et al, 2005). Skin is the only route of entry of cercariae, intervention 
at the level of skin penetration can be used to control the infection (Trottein et al, 
1999； Trottein et al, 1999a; Chen et al, 2002; Mohammod et al, 2004). 
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1.5 The Anti-inflammatory Protein, Sml6 
1.5.1 Discovery of Sml6 
The cercariae/schistosomulae elaborate substances that can modulate 
inflammatory responses in the skin and help the parasite to escape the host's immune 
detection. Upon stimulation, keratinocyte expresses, and secretes many biologically 
active molecules that mediate the immune response and may induce a secondary, 
blood cell-dependent, inflammatory response. The keratinocyte is thus the most 
important skin cell type for mediating inflammation. Inflammatory response is a 
cell-dependent process and depends heavily on genes regulation. The genes involved 
are regulated by specific transcription factors. Others anti-inflammatory compounds 
can act at different levels such as direct enzyme inhibition, repression of 
pro-inflammatory genes. 
Incubation of keratinocytes with soluble proteins that recovered from the 
excretory/secretory (ES) products of the schistosomulae of S. mansoni contain 
activities that down-regulate production of pro-inflammatory cytokines IL-la and 
IL-lp in human keratinocytes. Simultaneously, there was a significant increase in the 
production of the anti-inflammatory cytokines IL-lra in response to 
lipopolysaccharides (LPS) stimulation (Ramaswamy et al, 1995). 
Proteins in the ES products were separated in SDS-PAGE gel in non-reducing 
conditions, the desired band was cut and the proteins were eluted out for studies. Later 
studies of the proteins that separated from ES products have shown that the 
anti-inflammatory activity is associated with a protein of molecular mass 16.8kDa 
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(Sml6). It is the major IL-lra inducing substance in the ES products. Sml6 
suppresses antigen induced lymphoproliferative responses and reduction in antigen 
induced IL-2 secretion. These studies showed that schistosomulae of S. mansoni 
secrete an anti-inflammatory, immunomodulatory factor that may help the parasite to 
evade host immune responses in the skin. Given the capabilities of Sml6 to induce 
IL-lra and suppress lymphoproliferation, this protein may also have a potential use as 
a therapeutic agent for inflammatory skin disorders (Ramaswamy et al, 1996; Ram et 
al, 1999; Valle et al, 1999). 
1.5.2 Cloning and Expression of Gene-encoding Sml6 
Sml6 was first separated from the ES products by SDS-PAGE and blotted to 
PVDF membrane. Then N-terminus sequencing was performed to identify the amino 
acid sequence of Sml6. RNA isolated from the cercarial stage of S. mansoni was 
converted into single strand cDNA. The gene encoding Sml6 was amplified by PGR 
using specific designed primers. The gene was cloned into E. coli and baculovirus 
expression vector and expressed. The gene encoding Sml6 is of 500bp, with an open 
reading frame of 117aa that included an N-terminal signal peptide sequence of 18aa 
and there are 3 potential sites for phosphorylation but no glycosylation sites (Rao and 
Ramaswamy, 2000). 
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1.5.3 Potential Anti-inflammatory Therapy using Sml6 
A single intradermal injection of recombinant Sml6/GFP construct showed a 
significant suppression of cutaneous inflammation by reduction in cutaneous edema, 
decrease in neutrophil infiltration and suppression of pro-inflammatory cytokine 
expression. This provides a potential alternative therapy for treating inflammatory 
skin disorder (Rao et al, 2002). 
1.6 Innate Immunity and Adaptive Immunity 
The innate immune system comprises the first line of defense to infection in host. 
The goal of innate immune recognition is to discriminate between infectious nonself 
and noninfectious self (Firestein and Con, 2005). The innate immune recognition 
occurs via receptors that are expressed on all cells of a given type. These receptors are 
directly linked to a variety of defense mechanisms. The innate immune response is 
rapid, keeping an infection in check until cells of the adaptive immune system are 
able to mount a response. The innate response leads to production of important 
mediators that signal to other components of the immune system and helps 
coordinating the overall immune response. 
1.6.1 Macrophage 
The mononuclear phagocytes system (MPS) includes macrophages, reticular 
cells, endothelial cells, fibroblasts, histiocytes, and monocytes. The cells in the MPS 
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are derived from pluripotent hematopoietic stem cells in bone marrow that further 
differentiate into monoblasts, promonocytes, monocytes and mature to become tissue 
macrophages. Proliferation and differentiation of mononuclear phagocytes require the 
presence of a combination of polypeptide growth factors. These include macrophage 
colony-stimulating factor (M-CSF or CSF-1), granulocyte-macrophage colony 
stimulating factor (GM-CSF), interleukin-6 (IL-6), IL-3, stem cell factor, IL-1, 
leukemia inhibitory factor, and IFN-y (Sharon, 1998). 
Macrophages are part of the innate immune system; they recognize, engulf, and 
destroy potential pathogens, including bacteria, pathogenic protozoa, fungi and 
helminthes. Apart from their roles in primary innate immunity, macrophages function 
as regulator and effector cells in both humoral and cell-mediated immune responses in 
adaptive immunity. Upon phagocytosis, macrophages degrade proteins and process 
the antigens for presentation on major histocompatiblity complex (MHC) molecules, 
where T cells can recognize the substances as foreign. When activated, macrophages 
acquire microbicidal and tumoricidal activities by the reactive-oxygen species and 
reactive-nitrogen metabolites (Sharon, 1998). 
The destructive potential of macrophages and their ability to secrete regulators 
for the functioning of neighboring cells contribute to many aspects of homeostasis. 
The diversity of functions of macrophages provides a link between innate and 
acquired immunity and the numerous physiological changes in host defense. 
Mononuclear phagocyte development in an adult animal occurs in the bone 
marrow and passes through the following steps : pluripotent stem cells, committed 
stem cells, monocytes (bone marrow), monocyte (peripheral blood), and finally 
macrophage (tissues). Peritoneal macrophages are the primary macrophages in the 
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peritoneal lavage. With the stimulation, the resident macrophages adhere to the 
peritoneal lining, and there is a major influx of inflammatory cells. The inflammatory 
phenotype of these cells depends on the nature of the stimulus (Vodinelich and 
Lennox, 1987; Sasmono and Hume, 2004). 
1.6.2 Major Histocompatiblity Complex (MHC) 
T cell receptors on T lymphocytes usually recognize isolated antigenic 
determinants (antigen fragments) that are displayed on the surface of other host cells 
in non-covalent association with cell surface host molecules. The antigen fragments 
are often peptides. The peptides are from the intracellular degradation or processing of 
protein-containing antigens; some are exogenous antigens and some are endogenous 
antigens. The host's molecules are the major histocompatiblity complex (MHC) 
molecules. There are two classes of MHC molecules, class I and class II. Peptides that 
bind to MHC class I molecules are derived from endogenous antigens and range in 
length from 8 to 10 amino acids. The ends of the peptide are buried in complementary 
pockets of the MHC molecules. Peptides that bind to MHC class II molecules are 
derived from exogenous antigens and range in length from 12 to 20 amino acids. 
Unlike class I molecules, which bury the ends of bound peptides, MHC class II 
molecules allow peptides to extend out of the binding site (Sharon, 1998). 
1.6.3 Adaptive Immunity to Parasites 
Many parasites have complex life cycles with different developmental forms or 
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stages either extracellular or intracellular. Most parasites cannot be eradicated 
completely by host's immunity, and they usually establish chronic infection in the 
host. Such chronic parasitic infections are a major health problem because they affect 
30% of the world's population, predominantly in developing countries. 
The major adaptive response to worm infections is humoral immunity involving 
IgE antibodies that mediate ADCC by eosinophils. Shed antigens derived from worms 
are displayed in association with MHC class II molecules by phagocytic cells and 
activate CD4+ T cells. Mast cells, basophils, T cells and macrophages also participate 
in the adaptive immune response against worms. They assist binding of worm 
antigens to antiworm antibodies that are bound to mast cells or basophils causing 
degranulation to release the inflammatory mediators which lead to smooth muscle 
contraction; mucus secretion that help to expel the worms from host tissues and 
cytokines secretion to further stimulate the immune response (Sharon，1998b). 
1.7 Inflammation 
Inflammation is a physiologic response to a variety of stimuli such as infections 
and tissue injuries. Inflammation has many different causes. There are three frequent 
elicitors of inflammation : microorganisms - viruses, bacteria and eukaryotic parasites; 
cytotoxins; substances released from injured cells. 
Everyone experiences some form of inflammation, e.g. redness, pain, and 
swelling in injured or infected tissue caused by dilation, increased permeability of 
blood vessels and leukocytes invasion into the afflicted area. These characteristics are 
result of the body's defense and healing responses (Majno, 1998). Inflammation 
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involves various immune cells and mediators. The purpose of inflammation is to 
defense against pathogen invasion by interaction between leukocytes and immune 
mediators at sites of infection. Activation and accumulation of circulating leukocytes 
is a key factor in inflammation. Inflammation is carefully regulated by cytokines. A 
number of cytokines play significant role in the development of an acute or chronic 
inflammatory response, e.g. IL-1, IL-6, TNF-a. Pro-inflammatory cytokines such as 
IFN-y and IL-12 enhance the inflammatory response whereas the cytokine IL-10 
inhibits inflammation by decreasing the expression of pro-inflammatory cytokines 
(Poste & Crooke，1988). Inability to trigger a strong and appropriate inflammatory 
response may result in continued invasion of disease-causing agents (Decker, 1991). 
Although development of an effective inflammatory response can play an 
important role in the body's defense, the response can sometimes be detrimental. 
Rheumatoid arthritis, allergies, autoimmune diseases, microbial infections and 
transplant may initiate chronic inflammatory responses, which are undesirable 
(Cavaillon and Duff, 1999). For example, Rheumatoid arthritis (RA) is an 
autoimmune disease, caused by inflammation in the lining of joints. The symptoms 
are pain, stiffness, warmth, redness and swelling of joints. It is because the body's 
natural immune system does not operate as it should, the immune system attacks the 
healthy joint tissue and causes inflammation and joint damage. Anti-inflammatory 
drugs are used to relieve pain and reduce inflammation (Poste and Crooke, 1988). 
Current therapy for inflammation involves the use of anti-inflammatory drugs, 
which suppress the immune system. This carries a risk of infection and unwanted side 
effects, particularly when it is used over long periods. The anti-inflammatory drugs 
available at present treat only the symptoms, not the underlying causes of 
inflammation. Steroid and non-steroid anti-inflammatory drugs such as cortisone and 
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Vioxx are commonly used to combat inflammation. The undesirable side effects of 
the drugs on patients sometimes may be minor and sometimes may be fatal. So, there 
is an urge to discover a better anti-inflammatory drug which is more effective and 
causes fewer side effects to patients (Dinarello, 1991; Lin et al., 2004). 
1.7.1 Cells of the Inflammatory Process 
Cells participating in the inflammatory response are primarily those belonging to 
the mononuclear phagocytes system (MPS) which comprising the circulating and 
sessile tissue macrophages, monocytes and natural killer (NK) cells; also 
polymorphonuclear leukocytes (neutrophils, granulocytes), lymphocytes, mast cells 
(basophils), endothelial cells, fibroblasts and blood platelets (thrombocytes) (Chesney 
et al, 1998; Sawamura etal, 1998; Schroder, 1998). 
The immune cells and mediators participating in the inflammatory response are 
of different type and origin in response to different stimulation. Numbers of mediator 
molecules and other soluble components are involved in the inflammatory response : 
interleukins, interferons, tumor necrosis factor and transforming growth factors 
(Merinen et al., 2005). The releases of the immune mediators signal the presence of 
invader that has been recognized by the phagocytes and stimulate the other immune 
cells to destroy and get rid of the invaders. The antigen specific responses are 
mediated by circulating antibodies produced by B-lymphocytes and by T-cell 
involving mechanisms. The contact activation system comprises the coagulation 
system and involves activating surfaces of neutrophils, endothelial cells, and 
thrombocytes (Jacysyn et al., 2001). 
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1.7.2 Cytokines 
Inflammation is a complex immune response for body defense and different 
types of cytokines with different roles are involved. Endothelial cells play an essential 
role in inflammatory response. They are the interface between the injured tissues and 
recruited lymphocytes. The cytokines, such as IL-1, TNF activate the endothelial cells 
and leukocyte adherence to endothelium. The cytokines also involved in coagulation. 
Apart from inflammatory cytokines, there are also anti-inflammatory cytokines, 
IL-lra, IL-4 (Clemens, 1991). Inflammation initiated by infectious agents are potent 
activators of cytokine production, immune cells are major sources of cytokines 
(Cavaillon and Duff, 1999). 
Cytokines are defined as any soluble secreted regulatory proteins produced by 
both lymphoid and non-lymphoid cells that control the growth, survival, 
differentiation and effecting function of tissue cells. They are proteins or 
glycoproteins. Most of the cytokines act on cells in the immediate vicinity of the 
secreting cells. Thus they act in an autocrine or paracrine manner (Nicola, 1994; 
Meager, 1998). Cytokines are peptides or glycopeptides, secreted by host cells that 
influence the behaviour of other host cells or of cells that produced them. Cytokines 
exert their effects by binding to specific cell-surface receptors and initiating signal 
transduction to the interior of the cell, leading to activation of gene transcription. 
Cytokines mediate intercellular communications between the cytokine-producing 
cells and the cytokine-target cells; cytokines are sometimes referred to as intercellular 
messengers (Dealtry and Balkwill, 1987; Tan and Pedersen, 1998; Trinchieri, 2004). 
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Cytokines may cause the target cells to mature, to proliferate or differentiate, to 
undergo immunoglobulin class switching, to undergo apoptosis, or to perform effector 
functions. The actions of cytokines are often affected by other cytokines, this network 
of interaction is referred to as cytokine network. Typically, cytokines are produced 
and secreted in tiny quantities. They generally have high affinity for their receptors. 
Most cytokines can be produced by various cell types, although a particular cell type 
may represent the major source of a given cytokine. Cytokines bring about their 
biological effects by the specific interaction between its receptors. The binding of 
specific receptors on cell surface, activate the downstream intracellular signal 
pathways. The G proteins pathway and protein phosphorylation are two major 
signaling mechanisms (Baggiolini, 1991; Schraufstatter et al, 1998; Sharon, 1998a; 
Sprenger et al, 1998; Itoh and Arai, 1999) (Table 1.2). 
Table 1.2 Classes of cytokines and their functions. 
Cytokines Functions 
Interleukins Mediate communications among 
leukocytes 
Interferons Interfere with viral infection or infection 
by other intracellular microbes 
Tumor necrosis factors (TNF) Initiation of the inflammatory immune 
response to infection and sometimes to 
cancer 
Colony stimulating factors (CSF) Stimulate hematopoietic stem cells or 
progenitor cells to form colonies 
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Chemokines Chemotactic for leukocytes, recruiting 
them to sites of infection and thereby 
promoting the process of inflammation 
(modified from Sharon, 1998a) 
1.7.2.1 Interleukin-1 (IL-1) System 
There are two types of interleukin-1 (IL-1) : IL-1 a and IL-1 P. They are the most 
potent and multifunctional cell activators. The spectrum of action of IL-1 
encompasses cells of hematopoietic origin, from immature precursors to differentiated 
leukocytes. IL-1 plays an important role in immune and inflammatory responses 
(O'Neil and Greene, 1998; Prince et al., 2004; Fukushima et al., 2005). The 
production and action of IL-1 are regulated by multiple control pathways. The control 
system includes a specific activation system, IL-1-converting enzyme (ICE) and a 
receptor antagonist (IL-lra) (Symons et al, 1992; Mizel, 1988). There are two types 
of IL-1 receptors (IL-IR) : type I and type II (Labow et aL, 1997). The IL-lra binds to 
the same receptors as the IL-1 with similar affinity (Arend et al., 1998), but does not 
induce any biological responses (Dripps et al., 1991; Fischer et aL, 1992). IL-lra 
consists of two forms, secreted form (sIL-lra) and intracellular form (icIL-lra) 
(Irikura et a/., 2002). 
Many cell types are capable of producing IL-1, such as the peripheral blood 
monocytes, B and T lymphocytes. In keratinocytes, cells that made up 95% of the 
human epidermis can produce both IL-1 a and IL-lp upon stimulation (Symons et al., 
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1992). IL-1 can serve as a stimulant for induction of IL-2 synthesis, also IL-1 can 
enhance the functional activities and growth of a wide variety of inflammatory cells 
(Mantovani, 1999). The binding of IL-1 with its receptor may induce the N F - K B , 
STAT family of transcription factors family or the CCAAT/enhancer-binding protein 
(C/EBP), but little is known at this moment (Svotelis et aL, 2005). 
1.7.2.2 Interferon (IFN) System 
Interferon (IFN) was first reported by Isaacs and Lindenmann in 1957. 
Heat-inactivated Influenza virus, added to fragments of chicken chorioallanotic 
membranes, induced the formation of a substance, interferon, which, when added to 
fresh membranes, inhibited the growth of live Influenza virus (Isaacs and Lindenmann, 
1957). Interferons are classified into two types, type I and type II interferon. Type I 
IFN is produced by cells after stimulating with inducer or by virus infection. Type I 
IFNs are produced by almost all cell types and their actions are less cell-type or tissue 
specific. The proteins of type I IFN are similar in size. In mouse, the interferon alpha 
(MuIFN a) is a family of at least 14 subtypes (van Pesch et al., 2004). 
MHC class I molecules are polymorphic proteins that present portions of cellular 
peptides as antigens on the cell surface and are critical component to cellular immune 
response (Atta et al., 1995). MHC class I molecules are expressed almost ubiquitously 
in all cells. But tumors or abnormal cells express lower levels of MHC class I 
molecules on their surfaces (Sharon, 1998). Some peptides produced in viral 
infections or in neoplastic transformations could be recognized by proteosome as 
foreign antigens and thus be presented by MHC class I molecules (Sharon, 1998). IFN 
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a mainly positively regulate MHC class I molecules expression, while IFN y can 
modulate both MHC class I and class II molecules expression (Ljunggren et al., 1998). 
The augmentation of MHC class I molecules expression has been shown to effectively 
regulate and activate cytotoxic T lymphocytes, which are primary effectors of cellular 
immune responses (Sharon, 1998). 
1.7.3 Anti-inflammatory Therapy 
The administration of non-steroidal anti-inflammatory drugs (NSAIDs) can reduce 
pro-inflammatory cytokines and acute phase proteins production. NSAIDs comprise a large 
class of drugs : aspirin, Ibuprofen, Naproxen, COX-2 inhibitors. NSAIDs are cleared from 
the blood stream by the kidney. If patients take an NSAID for an extended period of time 
(six months or more), a blood test needs to be performed to check for early signs of kidney 
damage. NSAIDs may also cause stomach upset or possibly ulcers. Most types of NSAIDs 
have a variety of other potential nsks and complications associated with them, but most 
side effects are rare. The general side effects are : diabetes, heart disease, high blood 
pressure. So, there is an urge for the development of a safer and effect drug to combat 
inflammation. Research is being done to investigate the ant-inflammatory effect of 
flavonoids as alternative method over the use of NSAID (Lin et al” 2004). 
Recently, progress has been made on using anti-cytokine biological as the 
anti-inflammatory drugs to modulate the cytokine-driven inflammatory responses. 
Also, researches are done to investigate the potential involvement of toll-like 
receptors (TLRs) and their signaling pathway as novel therapeutic targets (Andreakos 
et ^ 7/.,2004). 
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1.8 Aim of Study 
Schistosoma japonicum is a common species in Asia that causes Schistosomasis. 
The Sjl6 gene, that corresponding to Sml6 in Schistosoma japonicum was cloned in 
this project. The aim of this project is to characterize Sjl6 and study the 
anti-inflammatory and immunomodulatory effect of Sjl6. 
Focus on the anti-inflammatory activity of Sjl6, it is speculated that these 
findings may help to find out the underlying mechanisms of the anti-inflammatory 
activity of Sjl6 with the host's immune system. In China, Schistosomiasis is a serious 
illness that affects lots of people. So, it is worthwhile to study the underlying 
mechanisms of the anti-inflammatory action of the parasites when they infect the host. 
Also, demonstrating the anti-inflammatory activity of Sjl6 might contribute to 
the development of an anti-inflammatory drug，as there is still no effective 
anti-inflammatory drug available. Further experiments might be done to analyze the 
interaction site of Sjl6 with its receptor. With the understanding of the molecular 
structures of Sjl6 and its receptor, we may be able to find or construct Sjl6 analogues 
for anti-inflammatory therapy. Effective anti-inflammatory therapy is in urgent need 
as inflammation related diseases affect millions of patients over the world. 
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Chapter Two : Materials and Methods 
2.1 Materials 
2.1.1 Cell Lines, Mouse Strain and Bacterial Strains 
1. WEHI 3B (JCS) murine myeloid leukemia cell line 
The JCS cells (Mak et al, 1993) were cultured in RPMI 1640 medium (Gibco, 
Carlsbad, US) supplemented with 10% fetal calf serum (FCS, Gibco), 50 U/ml 
penicillin, 50 |ag/ml streptomycin, and 10 j^g/ml neomycin (PSN, Gibco). The cultures 
were incubated under a humidified atmosphere of 95% air / 5% CO2 at 37°C. 
2. COS-1 monkey kidney cell line 
The COS-1 cells (ATCC no. : CRL-1650, Manassas, US) were cultured in 
Dulbecco's Modified Eagle Medium (DMEM，Gibco, Carlsbad, US) supplemented with, 
10% fetal calf serum (FCS, Gibco), 50 U/ml penicillin, 50 \xglm\ streptomycin, and 10 
l^g/ml neomycin (PSN, Gibco). The cultures were incubated under a humidified 
atmosphere of 95% air / 5% CO2 at 37�C. 
3. Escherichia coli, DH5a and BL21 
DH5a (Invitrogen, Carlsbad, US). BL21 (Novagen, Darmstadt, Germany). 
4. Mouse strain 
Female balb/c, 6-8 weeks old, provided by the Laboratory Animal Services Centre, 
the Chinese University of Hong Kong. 
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2.1.2 Plasmids 
1. pBluescript II SK(-) Stratagene 212206, La Jolla, US 
2. pEGFP-Nl Clontech 6085-1, Mountain View, US 
3. pET30a+ Novagen 69909-3, Darmstadt, Germany 
4. pSecTag2B Invitrogen V900-20, Carlsbad, US 
2.1.3 Chemicals 
1. Agar (Bacteriological grade) Ajax 863, Sydney, Australia 
2. Acetic acid, 99.8% RDH 33209，Seelze, Germany 
3. Acrylamide Amersham Biosciences 17-1304-01, 
Piscataway, US 
4. Amido black Bio-Rad 161 -0402, Hercules, US 
5. Ammonium persulphate (APS) Amersham Biosciences 17-1311-01 
6. Ampicillin Sigma A9518, St. Louis, US 
7. Bovine serum albumin (BSA) Sigma B6066 
8. 5-bromo-4-chloro-3-indolyl-p-D- Amresco 7240-90-6, Solon, US 
galactoside (X-gal) 
9. 5-bromo-4-chloro-3-indolyl phosphate Boehringer Mannheim 1585002, 
-4-toluidine salt (BCIP) Mannheim, Germany 
10. Bromophenol blue Bio-Rad 161-0404 
11. Calcium chloride, hydrated form Sigma C3881 
12. Cesium chloride - optical grade (CsCl) Sigma C4036 
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13. Chloroform Ajax 152 
14. Commassie brilliant blue R-250 Bio-Rad 161-0400 
15. Concanavalin A Sigma C0412 
16. 3-[Cyclohexylamino]-1 -propane Sigma C2632 
sulfonic acid (CAPS) 
17. Diethyl pyrocarbonate (DEPC) Sigma D5758 
18. N,N-dimethyl formamide (DMF) Sigma D4551 
19. Dimethyl sulfoxide (DMSO) for cell Sigma D2650 
culture 
20. Ethanol, absolute Ajax 214 
21. Ethidium bromide Invitrogen 15585-011 
22. Ethylenediamine-tetraacetic acid Sigma E5134 
(EDTA) 
23. Glycerol Sigma G7893 
24. Glycine Sigma G8898 
25. Guanidine thiocyanate Sigma G9277 
26. Hydrocloric acid, 32% Ajax 265 
27. Imidazole Sigma 12399 
28. Isopropyl-(3-D-thiogalactopyranoside Sigma 15502 
(IPTG) 
29. Kanamycin Sigma K1377 
30. Lauryl sulfate, sodium salt (SDS) Sigma L5750 
31. Magnesium chloride Sigma M9272 
32. Magnesium sulfate Sigma M2773 
33. Methanol Tedia MS 1922, Fairfield, US 
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34. N, N'-methylenebisacrylamide Amersham Biosciences 17-1304-02 
35. p-mercapto-ethanol Sigma M7154 
36. Nitro blue tetrazolium chloride (NBT) Roche 1-087-479, Mannheim, Germany 
37. Paraformaldehye Sigma P6148 
38. Peptone Difco 0118-01-8, Franklin Lakes, US 
39. Polyethylene glycol (PEG 6000) Merck 867491, Darmstadt, Germany 
40. Seakem LE agarose FMC 50004, Rockland, US 
41. Sodium acetate Sigma S8750 
42. Sodium azide Sigma S2002 
43. Sodium bicarbonate Sigma S5761 
44. Sodium chloride Sigma S9625 
45. Sodium hydroxide Sigma S5881 
46. Sodium phosphate Sigma S0876 
47. N-N-N'-N'- Sigma T9281 
Tetramethylethylenediamine (TEMED) 
48. Thiazolyl blue (MTT) Sigma M5655 
49. Tris-acetate EDTA (TAE) buffer Ameresco 796 
50. Tris base Amersham Biosciences 17-1321-01 
51. Triton X-100 Sigma T6878 
52. Trizol reagent Invitrogen 15596-026 
53. Trypan blue solution (0.4%) Sigma T8154 
54. Tryptone Oxoid L42, Basingstoke, UK 
55. Tween 20 Sigma PI379 
56. Yeast extract Difco 0127-17-9 
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2.1.4 Kits, Nucleic Acids and Reagents 
1. 1 kb plus DNA ladder™ Gibco 10787-026 
2. ABI Prism丁M dRhodamine terminator Applied Biosystem 403044, Foster City, 
cycle sequencing kit US 
3. ATP Amersham Biosciences 27-1006-01 
4. Cell proliferation ELISA, BrdU Roche 11 -647-229-001 
(colorimetric) kit 
5. DMRIE-C reagent Gibco 10459-014 
6. Freund's adjuvant, complete Sigma F5881 
7. Freund's adjuvant, incomplete Sigma F5506 
8. Hemacolor rapid staining set Merck 1.11661 
9. His bind purification kit Novagen 70239-3 
10. HiDi formamide Perkin Elmer 4311320, Wellesley, US 
11. 5X first-strand buffer; dithiothreitol Gibco 28025-013 
12. Pd(T)i2-i8 Amersham Biosciences 27-7858-01 
13. Protein assay dye reagent kit Bio-Rad 500-0006 
14. QIAEX II gel extraction kit Qiagen 20021, Germantown, US 
15. RNaseOUT Gibco 10777-019 
16. SDS-PAGE molecular weight standard, Bio-Rad 161-0317 
broad range 
17. Slide-A-Lyzer dialysis kit Pierce 66372, Rockford, US 
18. Ultrapure dNTPs sets Amersham Biosciences 27-2035-03 
19. Wizard® Plus SV minipreps DNA Promega A1460, Madison, US 
purification system 
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2.1.5 Antibodies and Immunoglobins 
1. Anti-His6 BM 1922416, Mannheim, Germany 
2. AP conjugated horse anti-mouse IgG (H+L) Vector AP-2000, Burlingame, US 
3. AP conjugated goat anti-rabbit IgG BM 1 214 632 
4. FITC conjugated mouse anti-mouse BD Pharmingen 553565, Franklin 
monoclonal antibody Lakes, US 
5. Mouse IgG Sigma 1538 
6. Rat IgG Sigma 14131 
7. S. japonicum uninfected rabbit serum * 
8. S. japonicum infected rabbit serum * 
* Provided by Dr. ZhongDao, Wu at Department of Parasitology, Sun Yat - Sen 
University of Medical Sciences, China. 
2.1.6 Cell Culture Reagents 
1. Antibiotic-antimycotic (PSF) Gibco 15240-062, 
Carlsbad, US 
2. Dulbecco's modified eagle medium (DMEM) Gibco 12800-017 
3. Dulbecco's phosphate-buffered saline (DPBS) Gibco 21600-010 
4. Fetal calf serum (FCS) Gibco 16000-044 
5. Geneticin (G418) Gibco 11811-031 
6. Penicillin-streptomycin-neomycin(PSN) mixture Gibco 15640-055 
7. RPMI 1640 (Powder) Gibco 23400-021 
8. Trypsin-EDTA Gibco 25200-056 
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2.1.7 Solutions 
1. Acrylamide 29.2 g acrylamide, 0.8 g N,N'-methylenebisacrylamide 
(SDS-PAGE) were dissolved in 100 ml distilled water, warmed to 
37�C to dissolve and degassed. 
2. Agarose gel, 1% 1% (w/v) agarose in Ix TAE buffer and autoclaved. 
3. AP Buffer 100 mM NaCl, 5mM MgCb, 100 mM Tris-Cl (pH9.5) 
(Western Blotting) 
4. Blocking solution 0.5 g non-fat dried milk was dissolved in 10 ml IX 
(Western Blotting) PBS (with 0.02% Tween 20) 
5. 5.7 M cesium Dissolve 96.0 g CsCl in 100 ml with 0.01 M EDTA (pH 
chloride 8.0). Then treated with DEPC and autoclaved. 
(M.W. = 168.37) 
6. Complete DMEM The DMEM powder was dissolved in distilled water 
medium and filter sterilized by passing through a 0.22 jam 
membrane. The complete medium was supplemented 
plain medium with 1% antibiotics (PSN or PSF) and 
10%FCS. 
7. Coomassie blue stain 2.5 g Coomassie blue was dissolved in 100 ml glacial 
(SDS-PAGE) acetic acid, 450 ml methanol and made up to 1 litre by 
distilled water. 
8. DEPC-treated water 0.1% DEPC was added to Milli-Q water and shaken 
vigorously. After treating overnight, the solution was 
autoclaved to degrade the remaining DEPC. 
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9. Destain solution 100 ml methanol, 100 ml glacial acetic acid and made 
(SDS-PAGE) up to 1 litre by distilled water. 
10. 0.5 M EDTA 18.61 g EDTA was dissolved in 100 ml distilled water 
(M. W. = 372.24) and adjusted to pH8.0 using NaOH. 
11. FACS fixative buffer 1% paraformaldehyde in 0.85% NaCl. 
12. FACS medium 2% FCS and 0.05% sodium azide in IX PBS 
13. 4M Guanidinium 50 g of guanidinium thiocyanate was dissolved in 10 
thiocyanate ml IM Tris-Cl (pH7.5) and made to 100 ml with 
(M.W. = 118.1) DEPC-treated water. Filtered through Whatman No.l 
homogenization buffer filter paper or equivalent, p-mercaptoethanol was 
added to a final concentration of 1 % (0.14 M) before 
use. 
14. Inclusion body 50 mM Tris-Cl (pH8.0), 1 mM EDTA, 0.2 mg/ml 
isolation solution lysozyme 
15. Inclusion body 1 M urea, 0.5% Triton X-100，50 mM Tris-Cl (pH8.0), 
washing buffer 1 mM EDTA 
16. LB agar / broth 10 g NaCl, 10 g Tryptone and 5 g Yeast Extract (for LB 
agar add 15 g bacterograde agar). Add with 1 liter of 
distilled water and autoclaved. 
17. LB+Ampio° agar / LB agar / broth added with filter sterilized ampicillin to 
broth final concentration of 100 jj.g/mL 
18. LB+Kan50 agar / LB agar / broth added with filter sterilized kanamycin 
broth to final concentration of 50 |Lig/ml. 
19. Phosphate buffer 140 mM NaCl, 2.7 mM KCl, 8 mM Na2HP04, 1.4 mM 
saline (PBS) KH2PO4 
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20. RF 1 solution 10 mM RbCl, 50 mM MnCh, 30 mM potassium 
acetate (pH 7.5), lOmM CaCb, 15% (w/v) glycerol 
were mixed and adjusted to pH5.8 with 0.2 M acetic 
acid. Filter sterilized by a 0.22 [xm membrane. 
21. RF 2 solution 10 mM MOPS, 10 mM RbCl，75 mM CaCb, 15% 
(w/v) glycerol were mixed and adjusted to pH 6.8 with 
NaOH. Filter sterilized by passing through a 0.22 |um 
membrane. 
22. Complete RPMI The RPMI powder was dissolved in distilled water and 
1640 medium filter sterilized by passing through a 0.22 jLim 
membrane. The complete medium was prepared by 
supplementing plain RPMI medium with 1 % 
antibiotics (PSN or PSF) and 10% FCS. 
23. IX SDS loading 50 mM Tris-Cl (pH6.8), 2% (w/v) SDS, 0.1% (w/v) 
buffer bromophenol blue and 10% glycerol were mixed. 1/20 
p-mercaptoethanol was added when use. 
24. lOX SDS running 30 g Tris-base, 144 g glycine, 10 g SDS were dissolved 
buffer in 1 litre of distilled water. 
25. 3M sodium acetate 123.04 g NaOAc was dissolved in 500 ml DEPC 
(M.W. 二 82.03) treated distilled water and adjusted to pH5.2 using 
glacial acetic acid. Treated with DEPC and autoclaved. 
26. 3% thioglycoUate 3 g dehydrated thioglycoUate powder was resuspended 
in 100 ml distilled water. Boiled to dissolve completely. 
27. Transfer Buffer 39 mM glycine, 48 mM Tris-base, 0.037% SDS, 
(Western Blotting) 20% methanol 
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2.1.8 Solutions of Reaction Kits 
ABgene Thermoprime^'"^ DNA Polymerase kit (ABgene, Epsom, UK) 
5X First-strand buffer 250 mM Tris-HCl, pH 8.3 at room temperature, 375 mM 
KCl, 15 mM MgCl2 
lOx Reaction buffer IV 200 mM (NH4)2S04; 750 mM Tris-HCl, pH 8.8 at 25�C; 
0.1%(v/v)Tween® 20 
Cell proliferation ELISA, BrdU (colorimetric) kit (Roche, Mannheim, Germany) 
BrdU labeling reagent 10 mM 5-bromo-2‘-deoxyuridine in PBS (7.4) 
FixDenat Secret formula 
Anti-BrdU-POD POD-conjugated monoclonal antibody 
Anti-body dilution solution Secret formula 
Washing buffer PBS 
Substrate solution 100 ml tetramethyl-benzidine (TMB) 
dRhodamine Terminator Cycle Sequencing Kit (Perkin Elmer, Wellesley, US) 
Terminator ready A-Dye terminator labeled with dichloro[R6G]; 
Reaction mix C-dye terminator labeled with dichloro[TAMRA]; 
G-dye terminator labeled with dichloro[Rl 10]; 
T-dye terminator labeled with dichloro[ROX]; 
AmpliTaq DNA polymerase, FS, with thermally stable 
pyrophosphatase; MgCh; Tris-HCl buffer, pH 9.0 
QIAEX II Gel Extraction Kit (Qiagen, Germantown, US) 
PE buffer Secret formula 
QXl Secret formula 
QIAEX II Secret formula 
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His Bind Purification Kit (Novagen, Darmstadt, Germany) 
8X Binding buffer 4 M NaCl, 160 mM Tris-Cl, 40 mM imidazole (pH7.9) 
8X Charge buffer 400 mM NiSC^ 
4X Elute buffer 4 M imidazole, 2 M NaCl, 80 mM Tris-Cl (pH7.9) 
4X Strip buffer 2 M NaCl, 400 mM EDTA, 80 mM Tris-Cl (pH7.9) 
8X Wash buffer 4 M NaCl, 480 mM imidazole, 160 mM Tris-Cl (pH7.9) 
Restriction Enzyme Digestion (Promega, Madison, US) 
lOX Buffer D 100 mM Tris-HCl; pH 7.5, 500 mM KCl; 70 mM MgCh; 
10 mM DTT 
lOX Ligase buffer 300 mM Tris-Cl (pH7.8), 100 mM MgCU 100 mM DTT 
Wizard® Plus SV minipreps DNA Purification System (Promega, Madison, US) 
Cell lysis solution 0.2 M NaOH and 1% SDS 
Cell resuspension solution 50 mM Tris-HCl, pH 7.5; 10 mM EDTA; 100 
|ig/ml RNase A 
Column wash solution 170 ml of 95% ethanol was added before use. Final 
concentration: 60 mM potassium acetate, 8.3 mM 
Tris-HCl, pH 7.5，40 pM EDTA, pH 8.0 and 60% ethanol 
Neutralization solution 4.09 M guanidine hydrochloride; 0.759 M potassium 
acetate; 2.12 M glacial acetic acid, pH 4.2 
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2.1.9 Enzymes 
1. EcoRI (25U/|al) Promega R601A, Madison, US 
2. EcoRV (lOU/^il) Promega R6351 
3. Lysozyme Sigma L6876, St. Louis, US 
4. M-MLV reverse transcriptase Gibco 28025-013, Carlsbad, US 
5. Platinum® Pfk DNA polymerase Gibco 11708-013 
6. T4 DNA ligase (SU/^il) Promega Ml801 
7. ThermoprimeP丨us DNA polymerase ABgene AB-0301，Epsom, UK 
8. Xhol (lOU尔 1) Promega R616A 
2.1.10 Major Equipments and Materials 
1. Bench-top microcentrifuge Eppendorf 5415D, Hamburg, Germany 
2. Capilliary PGR machine FTS-IS Corbett research, Sydney, Australia 
3. Centricon YM-50 Millipore 4243, Billerica, US 
4. Centrifuge 5414C Eppendorf 5414C 
5. Cuvette for Biophotometer (Uvette) Eppendorf 0030106.300 
6. DNA sequencer PE Applied Biosystems ABI Prism 310 
genetic analyzer 
7. ELISA plate reader Molecular Devices Spectra max 250 
8. Fluorescent Assisted Cell Sorter Becton Dickinson FACS Vantage 
9. Fluorescence analysis cabinet with Spectroline CC81 
EN-280C long/short wave UV lamp 
and white light lamp 
41 
10. Gel documentation system Bio-Rad GS-670 
11. Horizon™ 20.25 gel electrophoresis Gibco 1069BD 
apparatus 
and power supply 
12. Hybridization oven Hybrid 
13. Microcon YM-10 Millipore 42407 
14. Micro-cooler (for ligation reaction) VWR 13278-801 
15. Mini-Protean II 2D cell Bio-Rad 165-5960 
16. PVDF membrane Bio-Rad 162-0184 
17. Spectrophotometer Eppendorf 6131 000.012 
18. SpeedVac concentrator Savant SCllO 
19. Thermal cycler MJ research PTC-200 
20. Trans-Blot SD semi-dry electrophoretic Bio-Rad 170-3940 
transfer cell 
21. Transilluminators, white light UVP 95-0214-01 
22. Ultracentrifuge polyallomer tubes Beckman 270-233833, Fullerton, US 
23. Ultracentrifuge, SW60Ti Beckman XL-80 
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2.1.11 Primers 
2.1.11.1 Sequencing and Sjl6 Gene-coding Specific Primers 
Primer Primer sequence 5' - 3' 
MF390 Upper IGCA A A T G G G C G G T A G G T G T G T A 
pEGFP-Nl 
MF1046 Lower CGT CGC CGT CCA GCT CGA CCA G 
MF661 Upper CCG CGA AAT TAA TAG GAC TCA CTA 
pET30a+ 
MF596 Lower CTA GTT ATT GCT CAG CGG 
. MF978 Upper ATG AAA GTG ACG CCA ATT ATC TTC 
MF979 Lower CTA AGA CGA TTG ATA TTC CAT CAT C 
• MF980 Upper ATC TTC GCT CTA TTT TGT GTC GTA 
MF981 Lower CCA GTT TCT TCG CTA TGT ATT CC 
2.1.11.2 Primers for Cytokines 
Primer Code Primer sequence 5' - 3' Base 
pairs 
MF50 ITGC TCC ACT TCT CCA GCC AAG TGG CTC 
C-fms 607 
MF51 AGG TGT TCA CTG GAG CTC TCC TCT TCT G 
MF214 ACC ACA GTC CAT GCC ATC AC 
GAPDH 452 
MF215 TCC ACC ACC CTG TTG CTG TA 
MF142 ACA GTA TCA GCA ACG TCA AGC AA 
IL-1 a 546 
MF143 CCG ACT TTG TTC TTT GGT GGC A 
MF144 GAG CTT CAG GCA GGC AGT ATC 
IL-13 382 
MF145 GTA TAG ATT CTT TCC TTT CAG 
MF1071 GCT TTA CCT TCA TCC GCT CTG 
IL-lra 469 
MF1072 AGG GGT AGG GTG GGT GGT AG 
MF414 CCT CAA CAT GAA GAT TTC CAC AC 
MCP-5 335 
MF415 GTT TTT GGA ACT CTC AGC CTA GA 
MF160 GTA GCC ACA TGA TTG GGA ATG G 
M-CSF 304 
MF161 TCA TGG AAA GTT CGG ACA CAG G 
’ MF889 GAA GAT CTC TGC AGC TGC CCT 
RANTES 271 
MF890 GCT CAT CTC CAA ATA GTT GA 
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MF978 MF980 
1 a a a t c t t c c a g t a a a a t g a a a g t g a c g c c a a t t ate ttc get 
M K V T P I I F A 
4 3 gta ttt tgt gtc gta g g t g e t a t g a c a t t g a t e a c a g e t a c a 
V F C V V G A M T L I T A T 
85 a c g t t a gag c a a g c a c c t c a c c c g a g t g a a a a a g a c a t g g a a 
T L E Q A P H P S E K D M E 
127 t t a g t g t a t a t t g a t g c a g a a t a t g a a a a a g a a g g t gga c t g 
L V Y I D A E Y E K E G G L 
169 a a a t e a a t a t g c a a c gaa a t a a a a egg t e a t t c a g a a a a ggg 
K S I C N E I K R S F R K G 
211 c g c c a c c a c a t e t a t a a a g t t a t g g a t a a a t a t a t a egg a a g 
R H H I Y K V M D K Y I R K 
253 g a a g a t t t a g g c a t g a a a a t g t t a g a t g t t g c c a a a a t e c t t 
E D L G M K M L D V A K I L 
MF981 
295 gga a g a c g c a t t g a a a a a c g t a t g gaa tac ata gcg aag aaa 
G R R I E K R M E Y I A K K 
MF979 
337 ctg g a t a a g a t g a t g g a a t a t g a a t e g t c t t a g g t a t a t t t c 
L D K M M E Y E S S 
379 a t a a c a c a a t a g t t a a t a t t g t t g t g g a t t t e a g a c a a t g e t 
421 t t t t t c t g c t t t t t g t t t a c t a c t t t c t t a a t g a a t t t g a g e 
4 63 a a a t a a t a a aga t t g a t g a a a a a a a a a a a a a a a 
Fig. 2.1. Nucleotide sequence of Schistosoma mansoni anti-inflammatory protein, 
Sml6 mRNA : GeneBank AF269252. The gene specific primers : MF978/979 and 
MF980/981 are shown in shaded; bolded and underlined letters, respectively. The 
amino acid sequence of Sml6 was shown below the nucleotide sequence. 
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2.2 Methods 
2.2.1 Amplification of Sjl6 cDNA from Schistosoma 
japonicum Cercariae 
2.2.1.1 Isolation of Cercariae total RNA by Guanidinium 
Thiocyanate - Cesium Chloride Ultracentrifugation 
Cercariae total RNA was isolated by guanidinium thiocyanate-cesium chloride 
unltracentrifugation. The cercariae of Schistosoma japonicum were homogenized by 
4 M guanidinium thiocyanate solution with 1% p-mercapto-ethanol. The cell lysate 
was stored at -70�C. 
The frozen cell lysate was thawed at 65°C water bath and was further incubated 
at 65°C water bath for 5 minutes, then chilled on ice immediately. The cell lysate was 
passed through a 19G syringe needle for 50 times to shear the genomic DNA 
molecules. After shearing, approximately 2.5 ml of the cell lysate was laid on 1 ml 
5.7 M cesium chloride cushion in a DEPC treated polyallomer ultracentrifuge tube. 
Ultracentrifugation of the gradient was performed with SW60Ti rotor ultracentrifuge 
(Beckman, Fullerton, US) at 32,000 rpm, 18�C for 18 hours. 
After centrifugation, the supernatant above the cesium chloride cushion was 
removed by aspiration under vacuum. The ultracentrifuge tubes were inverted 
rapidly to discard the cesium chloride solution and air dried for 5 minutes. Then, the 
curved bottom of the tubes containing the clear RNA pellet was cut off with a new 
sterile scalpel blade. The RNA pellet was then rinsed out and resuspended with a total 
of 400 1^1 DEPC treated water (40 f^ l at one time) to a new eppendorf tube. 45 )il 3 M 
sodium acetate (pH5.2) and 1 ml absolute ethanol were added to the RNA suspension 
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and mixed well. The mixture was centrifuged at 14,000 rpm, 4°C for 30 minutes to 
obtain the RNA pellet. The RNA pellet was washed with 1 ml 70% ethanol to remove 
residual salts. Finally, the RNA pellet was vacuum dried for 5 minutes and dissolved 
in 50 |il of DEPC treated water and stored at -70°C. The quality and quantity of 
extracted RNA assayed by spectrophotometric measurement at 260 nm to 280 nm. 
2.2.1.2 Reverse Transcription - Polymerase Chain Reaction 
(RT-PCR) 
2.2.1.2.1 Reverse Transcription (RT) 
First strand cDNA was synthesized by reverse transcription (RT) reaction. 1 |ug 
of total RNA in a volume of 10 |il was incubated at 65°C for 5 minutes and chilled on 
ice immediately. The RNA was added into a RT reaction mixture of a total volume of 
10 jil which contained 200 units of Moloney Murine Leukemia Virus (M-MLV) 
reverse transcriptase (Gibco, Carlsbad, US), 0.2 mM of each dNTP (Amersham 
Biosciences, Piscataway, US), 0.1 |Lig oligo (dT)i2-i8 (Amersham Biosciences), 1 X 
first-strand buffer (Gibco), lOmM dithiotheritol and 40 units RNaseOUT (Gibco). The 
total reaction mixture with final volume of 20 was incubated at 37°C for 1 hour. 
The reaction mixture was diluted 10 fold with distilled water after the RT reaction and 
stored at -20°C. 
2.2.1.2.2 Polymerase Chain Reaction (PGR) 
Polymerase chain reaction (PGR) was performed to amplify the RT product. 
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40 |j.l of PCR reaction mix contained 2.5 units of thermoprime^^^^ DNA polymerase, 
1.5 mM MgCh，1 X reaction buffer IV (ABgene, Epsom, UK), 0.2 mM of each dNTP 
(Amersham Biosciences, Piscataway, US), and 50 pmole each of specific primers was 
added into 10 jil of RT product (0.1 i^g RNA) as the template for PCR amplification. 
PCR was performed by initial denaturation at 94°C for 2 minutes. The thermal 
cycle profile was : denatured at 94�C for 30 seconds, annealed at 57�C for 
MF978/979, 56�C for MF980/981 (the two pairs of designed Sjl6 gene specific 
primers) for 30 seconds and extended at 72°C for 30 seconds and the cycle was 
repeated for additional 29 cycles. After the last cycle, the reaction was further 
extended at 72�C for 10 minutes. 10 |il of amplified PCR products were 
electrophoresed at 100 V on 1% agarose gel with 0.25 ^g/ml ethidium bromide 
(Invitrogen, Carlsbad, US) to visualize the amplified band under UV illumination. 
The size of DNA fragments amplified with MF978/979 is 354 bp, the size of DNA 
fragments amplified with MF980/981 is 307 bp. 
2.2.2 Cloning and Subcloning of Sjl6 
2.2.2.1 Preparation of DH5a Competent Cells 
Frozen DH5a bacteria-glycerol was scrapped by sterile inoculation loop and 
streaked on LB agar plate. The plate was incubated at 37�C overnight. Single colony 
was picked and inoculated into 15 ml LB medium in a 150 ml flask. The bacterial 
culture was shaken overnight at 200 rpm, 37�C as a starter culture. 1 ml overnight 
starter culture was added to 100 ml pre-warmed LB medium (with 1:100 dilution) in a 
1 L flask and shaken at 200 rpm, 37°C until the optical density of the culture at 550 nm 
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reached 0.45 - 0.55 (with cell density around 5x10^ cells/ml). The culture was collected 
and incubated on ice for 15 minutes. The bacterial cells were harvested by 
centrifugation at 1,000 x g, 4�C for 15 minutes. The cell pellet was resuspended in 30 ml 
ice cold RFl solution. The cell suspension was incubated on ice for 15 minutes and 
harvested by centrifugation at 1,000 x g, 4�C for 15 minutes. The cell pellet was 
resuspended in 8 ml ice cold RF2 solution and incubated for 15 minutes on ice. 150 i^l 
cell suspension was aliquoted into chilled 1.5 ml eppendorf. The aliquoted competent 
cells were frozen by liquid nitrogen and stored at -70°C. 
2.2.2.2 Purification of Plasmid DNA 
The Wiz2ird®Phis SV Minipreps DNA Purification System (Promega, Madison, 
US) was used to purify the plasmid DNA from the bacterial cells. 
Bacteria-glycerol stock was scrapped by sterile inoculation loop and streaked 
onto LB plates supplemented with 50 jag/ml kanamycin (for the selection of 
pECFP-Nl, pET30a+ plasmid vectors) or 100 i^g/ml ampicillin (for the selection of 
pSecTag2B plasmid vector). The plates were incubated overnight at 37�C. Single, 
well-isolated colony was picked and inoculated into 15 ml LB medium supplemented 
with 50 i^g/ml kanamycin or 100 f^g/ml ampicillin in a 150 ml flask. The bacterial 
culture was shaken at 200 rpm, 37�C for 16 hours overnight. 
10 ml overnight bacterial culture was harvested by centrifugation at 5000 x g for 
15 minutes. The supernatant was discarded. The cell pellet was resuspended in 250 \i\ 
of cell resuspension solution by vortexing. 250 |il of cell lysis solution was added and 
mixed to lyse the cells and incubated at room temperature for approximately 5 
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minutes until the cell suspension was clear. 10 jj.1 of alkaline protease solution was 
added and mixed and incubated at room temperature for 5 minutes. 350 j^ l 
neutralization solution was added and mixed immediately to neutralize the cell lysate. 
The neutralized cell lysate was centrifuged at 14,000 rpm, room temperature for 30 
minutes. Cleared lysate was transferred carefully to the spin column in a 2 ml 
collection tube and centrifuged at 14,000 rpm, room temperature for 1 minute. The 
flow-through was discarded. 750 of column wash solution was added into the spin 
column and centrifuged at 14,000 rpm for 1 minute and the flow-through was 
discarded. Repeated with 250 column wash solution and centrifuged at 14,000 rpm 
for 2 minutes. The spin column was transferred to a new sterile eppendorf and the 
plasmid DNA was eluted by adding 100 |il of autoclaved Milli-Q water to the spin 
column and centrifuged at 14,000 rpm for 1 minute. The eluted plasmid DNA was 
stored at -20 °C. The quality and quantity of the extracted plasmid DNA was 
determined by measuring the optical density at 260 nm and 280 nm. 
2.2.2.3 Restriction Enzyme Digestion of DNA 
Plasmid vectors contain multiple cloning sites that have recognition sequences 
for many different restriction enzymes. The large variety of multiple cloning sites 
available make it possible to find a vector with restriction sites that are compatible 
with target DNA fragment to facilitate the process of cloning. 
Plasmids DNA of pBluescript II SK(-), pET30a+，pSecTag2B were prepared as 
described in materials and methods 2.2.2.2). 
1. pBluescript II SK(-) cloning vector (Stratagen, La Jolla, US) are designed to 
49 
simplify the cloning and sequencing procedures. 1 jig of pBluescript II SK(-) was 
digested with 4 units EcoRV (Promega, Madison, US), 2 10 X Buffer D 
(Promega), 0.2 \i\ BSA (10 |^ g/|Lil) (Promega) and made up to a final volume of 20 
1^1 with distilled water and incubated at 37°C overnight. 
2. Sj 16 gene was cut out from pBluescript II SK(-)/Sj 16 with the restriction enymes : 
EcoRJ (Promega, Madison, US) at 5' end and Xhol (Promega) at 3' end. 6 f^ g of 
pBluescriptll SK(-)/Sjl6 was digested with 4 units EcoRI and Xhol respectively, 
2 lOX Buffer D (Promega), 0.2 |li1 BSA (10 jug尔 1) (Promega) and made up to a 
final volume of 20 [i\ with distilled water and incubated at 37°C overnight. 
3. Expression vector pET30a+ (Novagen, Darmstadt, Germany) was cut, 1 jig of 
pET30a+ was digested with 4 units EcoRI and Xhol, 2 \i\ \0 X Buffer D, 0.2 
BSA (10 and made up to a final volume of 20 j^ l with distilled water and 
incubated at 37°C overnight. 
4. Expression vector pSecTag2B (Invitrogen, Carlsbad, US), 1 i^g of pSecTag2B 
were digested with 4 units EcoRI and Xhol, 2 10 X Buffer D, 0.2 BSA (10 
and made up to a final volume of 20 |il with distilled water and incubated 
at 37°C overnight. 
2 |il of digestion mix was electrophoresed at 100 V on 1% agarose gel with 0.25 
fig/ml ethidium bromide to check the completion of restriction enzyme digestion. The 
size of the Sj 16 cDNA fragment after restriction digestion was about 400 bp. 
2.2.2.4 Purification of DNA Fragments from Agarose Gel 
Plasmid vectors and target DNA fragments were purified from agarose gel using 
the QIAEX II Gel Extraction Kit (Qiagen, Germantown, US). 
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The digested DNA fragments prepared as described in materials and methods 
2.2.2.3 were resolved by gel electrophoresis in 2% agarose gel in autoclaved 1 X TAE 
buffer. After gel electrophoresis, the DNA bands of corresponding size were excised 
from the gel by sterile blades under UV illumination. The excised gel was put into a 
new 1.5 ml eppendorf and weighted. For each 100 mg gel slice, 300 ix\ of QXl Buffer 
was added to solubilize the agarose gel matrix. Then 10 )j,l of resuspended QIAEX II 
resin was added and the mixture was incubated at 65�C for 10 minutes. The mixture 
was vortexed every 2 minutes to keep QIAEX resin in suspension and thus enhancing 
DNA binding capacity. The suspension was centrifuged at 14,000 rpm for 30 seconds 
and the supernatant was discarded. The resin pellet was washed with 500 j^ l QXl 
Buffer and centrifuged at 14,000 rpm for 30 minutes and repeated twice with 500 fil 
PE Buffer. Finally, the resin pellet was air-dried for 15 minutes to remove any volatile 
PE Buffer and DNA was eluted by resuspending the pellet in 20 Milli-Q water. The 
suspension was centrifuged at 14,000 rpm for 1 minute to pellet the resin. The eluted 
DNA supernatant was transferred carefully into an eppendorf and stored at -20°C. The 
quality and quantity of the extracted plasmid DNA was determined by measuring the 
optical density at 260 nm and 280 nm. 
2.2.2.5 Ligation of Purified DNA Fragments 
25 ng of insert DNA fragments and 75 ng of vector DNA fragments were mixed 
with 1 |j.l of 10 mM ATP (Amersham Biosciences, Piscataway, US), 1 jil of 10 X T4 
DNA Ligase Buffer (Promega, Madison, US) and 4 units of T4 DNA ligase (Promega) 
in a final reaction volume of 10 jil. The reaction mix was incubated overnight at 16�C 
in the microcooler. 
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1. PGR amplified Sj 16 cDNA ligated with EcoRV digested pBluescript II SK(-) vector. 
2. Sj 16 cDNA fragment ligated with EcoRI and Xhol digested pET30a+ vector. 
3. Sj 16 cDNA fragment ligated with EcoRI and Xhol digested pSecTag2B vector. 
2.2.2.6 Transformation of Recombinant Plasmid 
Frozen bacteria-glycerol competent cell (150 j^ l) was thawed on ice. 10 p.! of 
ligated recombinant constructs was added to the competent cells. The mixture was 
chilled on ice for 1 hour. Heat-shock was performed by putting the tube in 42°C 
water bath for 2 minutes and then chilled on ice immediately. 800 \i\ of pre-warmed 
LB medium was added and shaken at 200 rpm, 37�C for 1 hour. Then the bacterial 
cell suspensions were ready for selection. 
2.2.2.7 Selection of Transformed Clones 
2.2.2.7.1 Screening by X-gal and IPTG : a-complementation 
LB agar plates supplemented with 100 )j,g/ml ampicillin were spread with 40 \x\ 
of X-gal (20 mg/ml) (Amresco, Solon, US) and 100 \x\ of 100 mM IPTG (Sigma, St. 
Louis, US) evenly. Then 50 i^l, 100 t^l, 200 550 i^ l of transformed bacterial cell 
suspension prepared as described in materials and methods 2.2.2.6 were spread on the 
plates. The plates were incubated upside down at 37�C overnight. 
The recombinant plasmids were identified by blue/white selection. Colonies that 
carried recombinant plasmids appeared white. The colonies carried the recombinant 
plasmids were selected, bacteria-glycerol stock was prepared and stored at -70�C • 
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122.12 Screening by Polymerase Chain Reaction 
LB agar plates supplemented with 50 |ig/ml kanamycin (pET30a+/Sjl6) or LB 
agar plates supplemented with 100 j^g/ml ampicillin (pSecTag2B/Sj 16) were spread 
with 50 III, 100 \x\, 200 550 |il of transformed bacterial cell suspension prepared as 
described in materials and methods 2.2.2.6. The plates were incubated upside down at 
37�C overnight. 
For pET30a+/Sjl6 and pSecTag2B/Sjl6, the transformants were screened by 
polymerase chain reaction (PGR) using Sjl6 gene specific primers. Well isolated, 
single colonies were picked randomly from plates and subcultured on a master plate 
and incubated overnight at 37°C. The master plates were stored at 4°C. The isolated 
colonies were resuspended in 100 |LI1 distilled water and the resuspension was boiled 
for 10 minutes. The resuspension was chilled on ice immediately after boiling and 
spun down the cell debris at 14,000 rpm for 5 minutes. 10 jil of supernatant which 
contained the DNA was used as template for PGR. PGR was done as described in 
materials and methods 2.2.1.2.2. The bacteria-glycerol stock of selected transformants 
were prepared and stored at -70�C • 
2.2.2.8 Cycle Sequencing 
The transformants with recombinant plasmids were screened and selected as 
described in materials and methods 2.2.2.7, the sequence of the clones were 
confirmed by DNA sequencing on Applied Biosystem ABI 3100 DNA sequencer. 
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ABI Prism™ dRodamine Terminator Cycle Sequencing Ready Reaction Kit (Applied 
Biosystem) was used for cycle sequencing. 
250 ng of plasmid DNA was mixed with 4 i^l of terminator ready reaction mix, 
1.6 pmol suitable sequencing primers. The sequencing primers for : pBluescript II 
SK(-)/Sjl6, upper MF978 / MF980, lower MF979 / MF981; pET30a+/Sjl6 : upper 
MF661, lower MF596; pSecTag2B/Sjl6 : upper MF978, lower MF979. The mixture 
was made up to a final volume of 10 |il with sterile distilled water. The template DNA 
was denatured at 96°C for 2 minutes and amplified for 25 cycles with the thermal 
cycle profile : 96°C for 30 seconds, 50�C for 15 seconds and 60�C for 4 minutes. 
After the cycle sequencing reaction, the PGR products were purified by ethanol 
precipitation and resuspended in 10|LI1 of HiDi formamide, vortexed and heated at 95 
�C for 5 minutes. The samples were chilled on ice immediately and transferred to 
MicroAmp® Optical 96-well Reaction Plate, covered by MicroAmp® Strip Caps. The 
samples were loaded on ABI Prism™ 3100 Genetic Analyzer for reading the 
nucleotide sequence. The samples were injected at 2.4 kV for 30 seconds, and 
electrophoresis was run at 12.2 kV，42�C for 140 minutes. Raw data of the 
sequencing reaction were collected by ABI Prism™ 3100 Genetic Analyzer 
Sequencing Analysis program. 
The sequenced nucleotide sequences were compared with the nucleotide and 
peptide sequence databases available at United State National Center for 
Biotechnology Information (NCBI, www.ncbi.nlm.gov) by Basic Local Alignment 
Search Tool (BLAST) to find out the similarity with other sequences. The Expert 
Protein Analysis System (ExPASy, www.expasv.org/) proteomics server of the Swiss 
Institute of Bioinformatics (SIB) was also used to analyze the peptide sequence. 
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2.2.3 Expression of the rSjl6 in Eukaryotic System 
2.2.3.1 Transfection of pSecTag2B/Sjl6 Plasmid into Animal Cells 
pSecTagl expression vector is designed for high-level expression in mammalian 
hosts. Potential stop codons have been removed from the multiple cloning sites to 
facilitate cloning in frame with the N-terminal and/or the C-terminal peptide. Proteins 
expressed from pSecTag2 are fused at the N-terminus to the murine Ig K-chain leader 
sequence for protein secretion. The pSecTag2B/Sj 16 constructs were transfected into 
COS-1 cells for recombinant protein expression (Kaufman, 1997). 
About 1x10^ COS-1 cells were seeded with 4 ml completed DMEM containing 
10% FCS in a 60-nm tissue culture plate (Nunc, Naperville, IL). Cells were incubated in 
a CO2 incubator at 37°C until the cells were 30-50% confluent. 
The following solutions were prepared in 1.5 ml eppendorf for 1x10^ COS-1 cells : 
1. Solution A: 0.75 ^g each of purified pEGFP-Nl and pSecTag2B/Sj 16 were 
diluted in 500 serum free DMEM medium. 
2. Solution B: 4 of DMIRJE-C reagent (Invitrogen, Carlsbad, US) was diluted 
into 1 ml serum free DMEM medium. 
Solution A and solution B were combined and mixed gently, incubated at room 
temperature for 45 minutes. The cultured cells were washed once with 2 ml serum free 
DMEM medium and overlaid with the lipid-DNA complex solution. The cells were 
incubated for 5 hours in a CO2 incubator. After that, the DNA containing medium was 
replaced with 4 ml of DMEM medium containing normal concentration of serum and 
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the cells were incubated at 37°C in CO2 incubator for 48 hours. And then the cells were 
subcultured at ratio 1:5, into a new culture flask containing the selection medium, 
Geneticin, G418 (Gibco, Carlsbad, US). The cells were cultured in selection medium 
and changed every 2 days. Transfected cells were diluted, seeded as one cell per well in 
a 96-well plate (Nunc, Naperville, IL) and selected by G418. Single, transfected clone 
was isolated and selected. The selection process was ongoing for about 10 passages until 
stable transfected clones were selected out. Single clone was subcultered in 25 ml 
culture flask (Nunc, Naperville, IL). 
2.2.3.2 PGR Screening of Transfected Cells 
Stable transfected clones prepared were screened by PCR screening. Cells were 
harvested by centrifugation at 2,000 rpm for 10 minutes, washed by distilled water 
and further centrifuged at 2,000 rpm for 10 minutes. The pellet was resuspeneded in 
distilled water and boiled for 10 minutes, chilled on ice immediately and spun down 
the cell debris at 14,000 rpm for 5 minutes. 10 of the supernatant which contained 
the plasmid DNA was used as template for PCR. PCR was done as described in 
materials and methods 2.2.1.2.2. 
2.2.3.3 Analysis of mRNA Transcript by RT-PCR 
The stably transfected cells were harvested by centrifugation at 1,500 rpm for 10 
minutes. The cells were washed twice with PBS. Cells pellets were resuspended in 
200 PBS by gently vortex and 3 ml, 4 M guanidinium thiocyanate solution was 
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added drop by drop into the cell suspensions. The cell lysate was stored at -70�C. 
Total RNA was isolated by guanidinium thiocyanate-cesium chloride 
unltracentrifugation as described in materials and methods 2.2.1.1. 
RT-PCR was performed with specific primers as described in materials and 
methods 2.2.1.2. The annealing temperature for MF214/215 (GAPDH) is 55°C, the 
amplified DNA fragments is 452 bp. 
2.2.3.4 Concentration of the Condition Medium 
The expressed recombinant protein was expected to be secretary and would 
secrete out into the cell culture medium. The transfected cell cultured medium 
(condition medium) was collected after 48 hours of incubation. The collected medium 
was centrifuged at 1,600 rpm for 10 minutes and the supernatant was transferred to a 
clean eppendorf and stored at 4�C. The concentration of the animal cells expressed 
recombinant protein might be very low to be detected by Western Blot, so the 
recombinant protein was concentrated using Centricon YM-50 (Millipore, Billerica, 
US) and Microcon YM-10 (Millipore). 
The large molecular size protein in FCS with nominal molecular weight about 
70,000 in the culture medium was first removed by Centricon YM-50 with the 
nominal molecular weight limit of 50,000. Sample reservoir was inserted into filtrate 
vial as instructed in the manual. 2 ml of condition medium prepared as described in 
materials and methods 2.2.3.1，was added into the sample reservoir without touching 
the membrane. The Centricon centrifugal device was spun at 5,000xg for 15 minutes. 
The filtrate vial was separated from membrane support base, the filtrate was collected. 
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About 1ml filtrate was saved which excluded the large molecule size serum protein 
and stored at 4°C. 
After removing the large molecular size serum protein, the recombinant protein 
in the condition medium was concentrated by Microcon YM-10 with the nominal 
molecular weight limit of 10,000 as the molecular weight of the recombinant protein 
is around 16,000. The Microcon sample reservoir was inserted into the filtrate vial, 
0.5 ml of filtrate saved above was added into the sample reservoir. The device was 
spun at 14,000 x g for 30 minutes. The filtrate vial was separated from the assembly, 
placed upside down in a new vial and then further spun for 3 minutes at 1,000 x g to 
transfer the concentrate to the vial. About 75 pil concentrate was saved which 
contained the concentrated recombinant protein and stored at 4�C. 
2.2.3.5 Western Blot Analysis of rSjl6 Expression 
10 of concentrate prepared above was treated with 2.5 5X SDS loading 
buffer and boiled for 10 minutes. After boiling, the sample was chill on ice 
immediately and spun down at 14,000 rpm for 5 minutes. 12 |LI1 of sample was loaded 
into a 12.5% SDS-PAGE gel and run at constant voltage of 100 V. 
For Western Blot, 6 pieces of 3 mm filter paper were cut into appropriate size 
and pre-soaked in transfer buffer. PVDF membrane was cut into appropriate size, 
wetted in 100% methanol and rinsed with transfer buffer. The assembly was set up by 
stacking 3 pieces of filter papers, the PVDF membrane, the SDS-PAGE gel and 
another 3 pieces of filter paper at the trans-Blot SD semi-dry electrophoretic transfer 
cell (Bio-Rad, Hercules, US) to transblot the protein onto PVDF. The size of the 
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recombinant Sjl6 is around 20 kDa, 15 V constant voltage was applied for 45 minutes. 
The membrane was removed and blocked in blocking buffer for 45 minutes. Natural 
Schistosoma japonicum infected rabbit serum and uninfected rabbit serum (control) 
(provided by Dr. Zhong Dao, Wu; Department of Parasitology; Sun Yat - Sen 
University of Medical Sciences; China) were used as primary antibody. Primary 
antibody was added with the dilution of 1:1000 in phosphate buffer saline (PBS) with 
0.02% Tween20 and incubated overnight at 4�C with shaking. The membrane was 
further shaken with primary antibody at room temperature for 30 minutes. The 
membrane was washed 3 times with PBS with 0.02% Tween20. The secondary 
antibody, AP conjugated goat anti-rabbit IgG (BM, Mannheim, Germany), was added 
with the dilution of 1:1000 in PBS with 0.02% Tween20 and incubated at room 
temperature for 1 hour. The membrane was washed 3 times with PBS with 0.02% 
Tween20, and then further washed with AP buffer. Color development was done by 
adding appropriate amount ofNBT and BCIP as substrate; for 10 ml AP buffer, 66 |al 
NBT and 33 [i\ of BCIP were added. The membrane was incubated at room 
temperature until color developed. Then, the membrane was washed with distilled 
water and air-dried at room temperature. 
2.2.4 Expression of rSjl6 in Bacterial System 
2.2.4.1 Transformation of pET30a+/Sjl6 Plasmid into BL21 
The pET system is a powerful system for cloning and expression of recombinant 
proteins in E, coli. The recombinant vector constructs were transformed into BL21 
bacterial host for expression as described in materials and methods 2.2.2.6. 
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2.2.4.2 Optimization of rSjl6 Expression 
The conditions for differential expression of the recombinant protein had to be 
optimized. It was done by analyzing the induced expression of recombinant protein at 
different time points in a particular incubation condition. 
pET30a+/Sjl6 transformed BL21 bacterial culture was shaken at 200 rpm, 37�C 
overnight as a starter culture. 200 \x\ of overnight starter culture was added to 20 ml 
pre-warmed LB medium supplemented with 50 ^ig/ml kanamycin (with 1:100 dilution) 
and shaken at 200 rpm, 37�C until the optical density of the culture at 600 nm 
reached 0.6-1.0. Then the culture was induced by IPTG with a final concentration of 
1 mM and shaken at 200 rpm, 37°C. 1 ml samples were collected at different time 
points : 0 hr, 0.5 hr, 1 hr, 1.5 hrs, 2 hrs，2.5 hrs, 3 hrs, 4 hrs and overnight. The 
collected samples were centrifuged at 14,000 rpm for 10 minutes. The pellets were 
resuspended in 200 |LII 5X SDS loading buffer and boiled the samples for 10 minutes 
and chilled on ice immediately, spun down at 14,000 rpm for 5 minutes. 12 j^ l of 
samples were loaded into 12.5% SDS-PAGE gel and run at a constant voltage of 100 
V to analyze the differential expression of the recombinant protein at different time 
points. The gel was stained with Coomassie blue and destained. 
2.2.4.3 Solubility of rSj 16 
The solubility of the expressed recombinant protein had to be determined by 
analyzing (i) the total bacterial cell lysate; (ii) the supernatant which contained the 
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soluble protein faction; (iii) the cell pellet and (iv) the inclusion body. 
1 ml of uninduced pET30a+/Sjl6 transformed BL21 bacterial culture was 
collected as uninduced control. IPTG was added with a final concentration of 1 mM 
to induce the expression of recombinant protein as described in materials and methods 
2.2.4.2. 1 ml of the induced bacterial culture was collected as induced control. The 
bacterial culture was split into two aliquots. The cells were harvested by 
centrifugation at 4,800 x g for 10 minutes and the pellets were resuspended in 2.5 ml 
inclusion body isolation solution. The resuspension was freeze-thawed in liquid 
nitrogen and 37°C water bath five times, (i) 1 ml total bacterial cell lysate from each 
aliquot was collected for analysis. The remaining resuspension was further 
centrifuged at 4,800 x g, 4�C for 20 minutes, (ii) 1 ml of supernatant which contained 
the soluble protein faction was collected for analysis. The supernatant was transferred 
to a clean eppendorf and further centrifuged at 4,800 x g for 10 minutes, (iii) The cell 
pellet of one aliquot was resuspended in 2.5 ml distilled water for analysis, (iv) The 
pellet of the other aliquot was washed with inclusion body washing buffer for 2 times, 
resuspended in 5.5 ml washing buffer and then centrifuged at 4,800 x g, 4�C for 20 
minutes for the analysis of inclusion body fraction. 
The samples for uninduced control; induced control; (i) the total bacterial cell 
lysate; (ii) the supernatant which contained the soluble protein faction; (iii) the cell 
pellet and (iv) the inclusion body were 4,800 x g for 10 minutes, resuspended in 5 X 
SDS loading buffer and boiled for 10 minutes. After boiling, the samples were chilled 
on ice immediately and spun at 14,000 rpm for 5 minutes. 12 |LI1 of samples were 
loaded into 12.5% SDS-PAGE gel and run at a constant voltage of 100 V, the gel was 
stained with Coomassie blue and destained. Then the samples were analyzed to 
determine the solubility of the recombinant protein. 
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2.2.4.4 Estimation of rSjl6 Concentration 
Bovine serum albumin (BSA) (Sigma, St. Louis, US) was used as standard to 
determine the concentration of the expressed recombinant protein. BSA was diluted 
with a range of 0.6, 0.5, 0.4，0.3, 0.2, 0.1 and 0.05 mg/ml. 10 |LI1 BSA standards, 
uninduced and induced pET30a+/Sjl6 samples were treated in 2.5 fil 5 X SDS 
loading buffer and boiled for 10 minutes. After boiling, the samples were chilled on 
ice immediately and spun at 14,000 rpm for 5 minutes. 10 \i\ of each BSA dilutions, 
uninduced and induced samples were loaded into a 12.5% SDS-PAGE gel and run at 
constant voltage of 100 V，the gel was stained with Coomassie blue and destained. 
The intensity of the induced band for recombinant protein against the BSA standards 
was compared to estimate the concentration of the induced recombinant protein. 
2.2.4.5 Western Blot Analysis of rSjl6 
To determine whether the recombinant Sjl6 shares similar protein structure as 
that of natural expressed Sjl6，10 j^ l of uninduced and induced pET30a+/Sjl6 culture 
were treated with 2.5 \ i \ 5X SDS loading buffer boiled for 10 minutes and loaded into 
a 12.5% SDS-PAGE gel and run at a constant voltage of lOOV. Western Blot was 
done as described in 2.2.3.5, by using the anti-serum raised in rabbit naturally infected 
with Schistosoma japoncium as the primary antibody. The infected rabbit serum 
contained the anti-bodies that against the protein expressed by S. japonicum. If the 
recombinant Sjl6 could be probed by the infected rabbit serum, this proved that 
recombinant Sjl6 is similar to a protein that expressed in natural S. japonicum. 
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2.2.5 Recombinant Protein Purification 
The pET30a+/Sjl6 expressed recombinant protein has a histidine-tag, specific 
histidine binding resin can be used for affinity chromatography to purify the 
his-tagged recombinant protein. The bacterial expressed recombinant protein was 
purified by the His bind purification kit (Novagen, Darmstadt, Germany). 
The constructs : pET30a+/SjCa8 (a generous gift from Miss Pecky Law, 
Department of Biology, CUHK) was used as his-tagged recombinant protein control. 
It was prepared in the same ways as the his-tagged recombinant Sj 16. 
2.2.5.1 Affinity Chromatography of Recombinant Protein 
IPTG induced bacterial culture was harvested by centrifugation at 4,800 x g for 
10 minutes. The supernatant was discarded. The pellet was drained completely and 
resuspended in 4 ml ice-cold 1 X binding buffer per 100 ml culture volume. The 
sample was sonicated on ice for 15 minutes. The lysate was centrifuged at 4,800 x g 
for 20 minutes to remove debris. The post-centrifugation supernatant was filtered 
through a 0.45 micron membrane to prevent clogging of the resins. 
Resins were packed in a column with the settled bed volume of 2.5 ml. The 
column was washed with 7.5 ml sterile distilled water, charged with 12.5 ml 1 X 
charge buffer and equilibrated with 12.5 ml 1 X binding buffer. Then the 4 ml lysate 
was loaded into the column and run at a flow rate of about 25 ml pre hour. Then the 
column was washed with 25 ml 1 X binding buffer, 15 ml 1 X wash buffer and eluted 
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with 15 ml 1 X elute buffer. After elution, the column was washed with 7.5 ml strip 
buffer. 1 ml of each portions were collected and treated with 250 5 X SDS loading 
buffer and boiled, then chilled on ice immediately and spun at 14,000 rpm for 5 
minutes. 10 jil of samples were loaded into 12.5% SDS-PAGE gel and run at a 
constant voltage of 100 V. The purification specificity of the his-tagged recombinant 
protein was analyzed by whether the recombinant protein could be specifically eluted 
out with the elution buffer. 
2.2.5.2 Dialysis of Eluted Recombinant Protein in PBS 
The elution contained high salt concentration together with the recombinant 
protein was not favorable for the assays in the later parts. So, the elution was 
dialyzed against phosphate buffer saline (PBS) using Slide-A-Lyzer Dialysis 
Cassette (Pierce, Rockford，US) with the molecular weight cut off at 7,000. 
The dialysis membrane was hydrated in PBS for 30 seconds. 5 ml elution 
prepared as described in materials and methods 2.2.5.1 was injected into the dialysis 
cassette by a syringe. The dialysis cassette was covered by polyethylene glycol (PEG 
6000) to absorb as much water as possible to reduce the volume so as to concentrate 
the protein before dialysis. Then, the dialysis cassette was dialyzed against 2 L PBS at 
4�C for 1 hour with stirring. After that, 2 L new dialysis buffer (PBS) was replaced 
and further dialyzed at 4�C, overnight with stirring. About 1 ml dialyzed sample was 
collected using syringe and stored at 4�C. 250 \i\ dialyzed sample was treated with 
5 X SDS loading buffer and boiled for 10 minutes, chilled on ice immediately and 
spun at 14,000 rpm for 5 minutes. 10 j^ l of samples were loaded into a 12.5% 
SDS-PAGE gel and run at a constant voltage of 100 V to analyze the dialyzed sample. 
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2.2.5.3 Estimation of Recombinant Protein Concentration 
Protein Assay Dye Reagent Concentrate (Bio-Rad, Hercules, US) was used to 
estimate the concentration of protein in the samples. The dye reagent was prepared 
freshly by diluting 1 part of Dye Reagent Concentrate with 4 parts of distilled water 
and filtered through Whatman #1 filter to remove particulates. Linear range of BSA 
standard : 0.00, 0.02, 0.04，0.06, 0.08，0.10 mg/ml was prepared. 0.5ml diluted dye 
reagent was added to 100 of each standards and samples prepared as described in 
materials and methods 2.2.5.1 and 2.2.5.2 and vortexed. The samples were incubated 
at room temperature for 10 minutes and the absorbance was measured at the optical 
density of 595 nm by the spectrophotometer to estimate the protein concentration of 
the eluted and dialyzed samples. The samples were assayed in triplicate. 
2.2.6 Demonstrate the Anti-inflammatory Activity of rSjl6 
2.2.6.1 Thioglycollate Induced Macrophage Recruitment 
Three, eight weeks old female balb/c mice were used in each group : PBS, rSjCaS 
and rSjl6. For PBS group, 2ml of PBS was injected into the peritoneal cavity of the 
mice. For rSjCaS and rSjl6 group, 0.1 mg of dialyzed recombinant protein was injected 
into the peritoneal cavity of the mice. The protein concentration of dialyzed rSjCaS is 
0.04 mg/ml as estimated in materials and methods 2.2.5.3, so 2.5ml was injected into the 
peritoneal cavity of each mouse. The protein concentration of dialyzed rSj 16 is 0.05 
mg/ml as estimated in materials and methods 2.2.5.3, so 2 ml was injected into the 
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peritoneal cavity of each mouse. One hour after the injection of PBS or recombinant 
protein, each mouse was injected with 1 ml 3% thioglycollate (a generous gift from Dr. 
K.N. Leung, Department of Biochemistry, CUHK) and incubated 3 days for macrophage 
recruitment. 3 days after, the mice were cervical dislocated to harvest the peritoneal 
eluted cells for the analysis of the cell populations and cell morphology. 
The total peritoneal eluted cells (PECs), with macrophage and other immune cells 
were counted. Then the cells were incubated in a CO2 incubator at 37°C for 3 hours to 
allow adherence of the macrophages on the bottom of the culture dish, the non-adherent 
cells were washed away gently with warm PBS. The adherent cells were detached from 
the culture dish by using 1 mM EDTA and pipetted up-and-down, the number of the 
adherent cells and non-adherent cells were counted. 
2.2.6.2 Cytospin and Hemacolor Staining of PECs 
Microscopic slides were cleaned with 70% ethanol and assembled on the clipper 
by assembling the filter card between the sample chamber and microscopic slide. The 
whole setup was stood vertically and 5x10"^  in 100 |LI1 cell suspensions were applied to 
the sample chamber. The setup was spun at 500 rpm for 5 minutes in the cytocentrifuge 
and air-dried. Fixed cells were stained using the Hemacolor rapid staining kit (Merck, 
Darmstadt, Germany). For Hemacolor staining, the smear was immersed into solution 1 
five times for 1 second each time. Then the smear was immersed into solution 2 three 
times for 1 second each and further immersed into solution 3 six times for 1 second each. 
The smear was rinsed with buffer solution (pH7.2) and air-dried. The stained smear was 
embedded with mounting medium. The morphology of the cells was observed under 
microscope. The nuclei were red and the cytoplasm was stained blue. 
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2.2.6.3 FACS Analysis ofPECs 
The distribution of different PECs population were analyzed by flow cytometry on 
forward scatter (FSC) and side scatter (SSC). The forward scatter is proportional to the 
diameter of the cells, the side scatter is proportional to the granularity. Different cell 
populations have different FSC and SSC values. 1x10^ total peritoneal eluted cells were 
fixed by FACS fixative and analyzed by flow cytometry using the Fluorescent Assisted 
Cell Sorter (FACS) (Becton Dickinson FACS Vintage). 
2.2.6.4 Isolation of total RNA by TRIZOL Reagent 
The peritoneal epithelial tissues of the treated mice were removed and total RNA 
was isolated by TRIZOL reagent (Invitrogen, Carlsbad, US). The cytokines expression 
profile was studied by RT-PCR (Favre et al, 1997). 
The tissue was cut into small pieces and grinded against a sieve to get the single 
cell suspension. The cells were centrifuged at 1,500 rpm, 4�C for 10 minutes and cell 
number was counted. 1 ml of TRIZOL reagent was used per 5X10^ cells to 
homogenize the cells by repetitive pipetting up-and-down. The homogenized samples 
were incubated at room temperature for 5 minutes to permit the complete dissociation 
of nucleoprotein complexes. Then 2 ml chloroform was added per 1 ml of TRIZOL 
reagent, the tubes were capped securely, shaken vigorously for 15 seconds and 
incubated at room temperature for 3 minutes. The samples were centrifuged at 10,000 
rpm，4�C for 15 minutes. Followed centrifugation, the mixture was separated into a 
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lower red phenol-chloroform phase, an interphase, and a colorless upper aqueous 
phase. The upper aqueous phase which contained the RNA was transferred to a clean 
tube. The RNA was precipitated from the aqueous phase by mixing with 0.5 ml 
isopropyl alcohol. The samples were incubated at room temperature for 10 minutes 
and centrifuged at 10,000 rpm, 4°C for 10 minutes. The supernatant was discarded 
and the colorless RNA pellet was washed with 75% ethanol and centrifuged at 7,500 
rpm, 4�C for 5 minutes. The supernatant was discarded and the RNA pellet was 
air-dried briefly. The RNA was dissolved in 500 DEPC-treated water by repetitive 
pipetting up-and-down and stored at _70°C. The quality and quantity of extracted 
RNA was determined by measuring at optical density 260nm and 280nm. 
The cytokine expression profile was studied by RT-PCR as described in 
materials and methods 2.2.1.2. The annealing temperature for different cytokines 
specific primers are : 56�C for IL-lra, IL-1 a, IL-4, IL-8, IL-10, MCP-5, M-CSF; 55 
�C for GAPDH, IL-1 (3, IL-2; 7 2 � C for C-fms; and 48°C for RANTES. 
2.2.7 Immunogenicity and Antigenicity of rSj 16 
Immunogenicity of a substance is its ability to or the degree to provoke an 
immune response. Antigenicity is the ability of a molecule to stimulate the production 
of antibodies. The immunogenicity was tested by assessing the ability of rSjl6 to raise 
antibodies in immunized mice. The antigenicity of recombinant Sjl6 was tested by its 
ability to be recognized by the Schistosoma japonicum infected rabbit serum and UV 
radiated infected rabbit serum using Western Blot 
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2.2.7.1 Western Blot of rSjl6 with Schistosoma japonicum Infected 
Rabbit Serum 
10 of uninduced and induced pET30a+/Sjl6 samples were treated with 5 X 
SDS loading buffer boiled for 10 minutes, chilled on ice immediately and spun at 
14,000 rpm for 5 minutes. 10 i^l sample was loaded into a 12.5% SDS-PAGE gel and 
run at a constant voltage of 100 V. Western Blot was done as described in materials 
and methods 2.2.3.5. Anti-serum raised in rabbit naturally infected with S. japonicum 
cercariae; anti-serum raised in rabbit naturally infected with UV irradiated S. 
japonicum cercariae; and uninfected rabbit serum (provided by Dr. Zhong Dao, Wu; 
Department of Parasitology; Sun Yat - Sen University of Medical Sciences; China) 
were used as primary antibody in the dilution of 1:1000 in PBS with 0.02% Tween20. 
The secondary antibody, AP conjugated goat anti-rabbit IgG (BM, Mannheim, 
Germany), was added in the dilution of 1:1000 in PBS with 0.02% Tween20 
2.2.7.2 Preparation of Anti-Sjl6 Serum 
The recombinant protein is immunogenic if it can provoke the immune response 
of the mouse to produce anti-bodies against it. 
For immunization of the mouse, 
To immunize one mouse, 25 |ag of recombinant protein was required in each 
injection. Induced pET30a+/Sjl6 bacterial culture was harvested by centrifugation at 
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4,800 X g for 10 minutes. The pellet was resuspended in 5 X SDS loading buffer and 
boiled for 10 minutes, chilled on ice immediately and centrifuged at 14,000 rpm for 5 
minutes. The samples were separated by 12.5% SDS-PAGE gel and run at 100 V 
constant voltage. The gel was stained in Coomassie blue for 1 hour and destined for 3 
hours to visualize the induced band. The gel was washed in distilled water thoroughly. 
The induced band was cut out using a clean blade and stored in eppendorf at -70�C. 
The cut gel was grinded into a paste using pestle and mortar, then transferred to an 
eppendorf and spun down briefly. Equal volume of Freund's adjuvant was added, 
vortexed to mix. The mixture was run through a 23G syringe to sheer the large pieces. 
For first immunization, complete Freund's adjuvant (Sigma, St. Louis, US) was used. 
After the first immunization, the first and second boosters were injected at 2 weeks 
intervals. For first and second boosters, incomplete Freund's adjuvant (Sigma, St. 
Louis, US) was used. Immunized mouse serum was collected 10 days after the last 
booster using a sharp blade to cut a small wound at the tail and about 800 [i\ of blood 
was collected from one mouse. The blood was settled at 4�C for 30 minutes and 
centrifuged at 14,000 rpm, 4�C for 30 minutes. The clear supernatant was transferred 
to a clean eppendorf and further centrifuged at 14,000 rpm, 4�C for 30 minutes. The 
supernatant was collected, aliquoted and stored at -20�C 
2.2.7.3 Western Blot of rSjl6 with Immunized Mice Serum 
Western Blot was done as described in materials and methods 2.2.3.5. 
Unimmunized and rSj 16 immunized mouse serum were used as primary antibody and 
added with the dilution of 1:1000 in PBS with 0.02% Tween20 against the uninduced 
and induced recombinant protein samples. The secondary antibody, AP conjugated 
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horse anti-mouse IgG (H+L) (BM, Mannheim, Germany) was added with the dilution 
of 1:1000 in PBS with 0.02% Tween20. 
2.2.8 FACS Analysis of MHC (I) Expression 
Flow cytometry is a powerful technique for cell surface antigen analysis, it was 
used to analyze the level of MHC (I) expression on JCS cell surface. MHC (I) is the 
major histocompatibility complex class I molecule and expressed on the surface of 
almost every cells, its role is to bind and present antigen on the surface of cells for the 
recognition by lymphocytes (Luder et aL, 1998; Luder et al., 2001). Interferon (IFN)-a 
is capable of up-regulating the MHC (I) expression (Nguyen et al., 2001; Keir et al., 
2002). rMuIFN-a4 (a generous gift from Mr. Lawrence Tsang, Department of Biology, 
CUHK) is shown to have the MHC (I) up-regulatory effect by Lawrence Tsang. 
1x10^ JCS cells were seeded in a 6 well-plate (Nunc, Naperville, IL) and incubated 
in different conditions with a final volume of 2 ml for 48 hours. The cells were 
harvested by centrifuging at 1,500 rpm, 4°C for 5 minutes and washed with FACS 
medium twice and resuspended in 1 ml FACS medium. The cell numbers were counted. 
1x10^ cells were resuspended in 200 |al FACS medium. 2 |Ltl rat IgG (10 j^g/ml) (Sigma, 
St. Louis, US) and 2 i^l mouse IgG (10 |ag/ml) (Sigma，St. Louis, US) were added and 
incubated in 4 � C for 30 minutes with occasional shaking. The cells were washed twice 
with FACS medium and resuspended in 50 FACS medium. 50 diluted (1:100) 
FITC-conjugated anti-mouse antibody (BD Pharmingen, Franklin Lakes, US) 
was added. The samples were incubated at 4�C for 30 minutes and washed twice with 
FACS medium. Finally the pellets were resuspended in 600 FACS fixative. The 
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effect of rSjl6 on the rMuIFN-a stimulated MHC (I) up-regulation in JCS cells was 
measured by the Fluorescent Assisted Cell Sorter (FACS) (Becton Dickinson FACS 
Vintage. The results were analyzed by the software WinMDI 2.9. 
2.2.9 Anti-proliferative Assay using BrdU Kit 
The anti-proliferative effect was studied by the Cell Proliferation ELISA, BrdU 
(colorimetric) kit (Roche, Mannheim, Germany). It is a colorimetric immunoassay for 
the quantification of cell proliferation which based on the measurement of BrdU 
incorporation during DNA synthesis (Maghni et al, 1999). 
1x10^ JCS cells were cultured in different conditions in a final volume of 200 
in a 96-well flat-bottomed culture plate (Nunc, Naperville, IL) at 37°C for 54 hours. 
20 BrdU was added to the cells and reincubated 8 hours for incorporation of 
pyrimidine analogue BrdU in place of thymidine into the DNA of proliferating cells. 
The culture plate was centrifuged at 300 x g for 10 minutes and the labeling medium 
was removed. The cells were fixed by 200 jil FixDenat and incubated at room 
temperature for 30 minutes. The FixDenat was removed thoroughly by flicking off 
and tapping. 100 \Ji\ anti-BrdU-POD was added and incubated at room temperature for 
90 minutes to bind the BrdU that incorporated in the newly synthesized DNA. 
Antibody conjugate was removed by flicking off and rinsed with 200 jj.1 washing 
buffer for three times. Washing buffer was removed by tapping. The complexes were 
detected by 10 )j.l substrate solution. The reaction product was quantified by 
measuring the absorbance at 370 nm using the ELISA reader. The results were 
analyzed by the software GraphPad Prism 4. 
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Chapter Three : Results 
3.1 Amplification of Sjl6 cDNA from Schistosoma 
japonicum Cercariae total RNA 
A protein, Sml6.8 was first discovered in the secretion of the schistosomulae of 
Schistosoma mansoni and proved to have anti-inflammatory and immunomodulatory 
functions (Ramaswamy et al., 1996). Later, the protein was renamed as Sml6 and the 
gene encoding Sml6 was cloned and partially characterized (Rao and Ramaswamy, 
2000). The nucleotide sequence of Sml6 showed 100% identity with SmSPO-1 (Ram 
et al, 1999) and suggested that SmSPO-1 and Sml6 may be the same. 
The contraction pathway for both Schistosoma mansoni and Schistosoma 
japonicum are through the penetration of the skin so we suspected that in Schistosoma 
japonicum may have a protein with similar role as Sml6 to evade host immune 
system. Based on the nucleotide sequence of Sml6, S. mansoni anti-inflammatory 
protein, gene specific primers were designed using the computer program OLIGO™ 6 
(Fig. 2.1). The two pairs of primers : MF978/979 and MF980/981 were designed for 
cloning the S. mansoni anti-inflammatory protein's (Sml6) corresponding gene in S. 
japonicum The S. japonicum cercariae total RNA was isolated by guanidinium 
thiocyanate-cesium chloride unltracentrifugation. Using the primers : MF978/979 and 
MF980/981, DNA fragment was amplified from S. japonicum cercariae RNA by 
RT-PCR as described in (materials and methods 2.2.1). The PCR products were 
electrophoresed in 1% agarose gel and stained with 0.25 |ig/ml ethidium bromide. The 
amplified band was visualized under UV illumination (Fig.3.1). The Sml6 
corresponding gene in S. japonicum was amplified and named as Sjl6. 
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M MF978/979 MF980/981 
300 bp _ ^ ^ s i ^ ^ ^ M I S H m i 
h B I 
H H H H I ^ ^ B I 
Fig. 3.1. Detection and amplification of Sjl6 gene in S. japonicum cercariae RNA 
by RT-PCR. Total RNA of S. japonicum cercariae was used as template for the 
amplification of Sjl6 cDNA by PGR, using gene specific primers : MF978/979 or 
MF980/981 as indicated and described in materials and methods 2.2.1. M : 1 kb plus 
DNA ladder. The specific primers used to amplify the DNA band were indicated at the 
top. The arrow indicated the size of 300 bp. 
300 bp • 
Fig. 3.2. The purified PGR amplified products from Fig. 3.1 using QIAEX II gel 
extraction kit. The PGR products that were amplified using MF978/979 or 
MF980/981 primers was extracted and purified from agarose gel by QIAEX II gel 
extraction kit. M : 1 kb plus DNA ladder. The specific primers used were indicated at 
the top. The arrow indicated the size of 300 bp. 
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3.2 Construction of pBluescript II SK(-) / Sjl6 
The Sjl6 gene amplified as described above was cloned into pBluescript II SK(-) 
vector to facilitate the later cloning and sequencing procedures. The outline of 
construction of pBluescript II SK(-)/Sjl6 is shown (Fig. 3.3). The Sjl6 gene was 
successfully amplified by RT-PCR with specific primers : MF978/979 and 
MF980/981 (Fig. 3.1). The amplified PGR product was purified from agarose gel by 
QIAEX II gel extraction kit (Qiagen, Germantown, US) (Fig. 3.2). The pBluescript II 
SK(-) vector was digested with EcoRV to generate blunt ends and ligated with the 
amplified PGR products (materials and methods 2.2.2.3 and 2.2.2.5). The recombinant 
plasmids were transformed into DH5q competent cells by heat-shock (materials and 
methods 2.2.2.6). Competent cells were prepared as described in materials and 
methods 2.2.2.1). The transformants were selected by blue-white selection (materials 
and methods 2.2.2.7.1). The pBluescript II SK(-) that carried the inserts, produced 
white colonies. The white colonies were picked and sequenced (materials and 
methods 2.2.2.8). The sequencing result of the transformant, pBluescript II SK(-)/Sjl6, 
using Sjl6 gene specific primers : MF978/979 as sequencing primers was shown (Fig. 
3.4). The Sjl6 full-length cDNA was cloned successfully. The Sjl6 full-length cDNA 
sequence has 354 bp. 
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S. japonicum cercaria total RNAs 
RT-PCR 
MF978 / MF980 ^ 
5' ^ 3, 
MF979/MF981 
〔二��1" (,) on 
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— 
ampicii.rn/ / QCZ ^^^^^^^mmmm 
I pBluescript II8K (-) S 
H \ / Sj l6cDNA \ / “——“ 
PUC- ORR ^ ^ 
Ligation of the PCR amplified Sj 16 cDNA with the 
EcoRV digested pBluescript II SK(-) vector 
t-l or 
n 卜）or丨、�i 
omp,cH n -/ / j ^ acZ • 
I ypBluescript IISKH/8J16 Bsjie I 
b I • 
\又 严P lac 
PLK. ORR 
Fig. 3.3. Outline of the construction of pBluescript II SK(-)/Sjl6. 
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Sjl6 sequence (354bp) 
vector sequence ^ 
• 
1 G G A T C C C C C G G G C T G C A G G A A T T C G A T T A T G A A A G T G A C G 
MF978 • 
4 1 C C A A T T A T C T T C G C T G T A T T T T G T G T C G T A G G T G C T A T G A 
8 1 C A T T G A T C A C A G C T A C A A C G T T A G A G C A A G C A C C T C A C C C 
1 2 1 G A G T G A A A A A G A C A T G G A A T T A G T G T A T A T T G A T G C A G A A 
1 6 1 T A T G A A A A A G A A G G T G G A C T G A A A T C A A T A T G C A A C G A A A 
2 0 1 T A A A A C G G T C A T T C A G A A A A G G G C G C C A C C A C A T C T A T A A 
2 4 1 A G T T A T G G A T A A A T A T A T A C G G A A G G A A G A T T T A G G C A T G 
2 8 1 A A A A T G T T A G A T G T T G C C A A A A T C C T T G G A A G A C G C A T T G 
3 2 1 A A A A A C G T A T G G A A T A C A T A G C G A A G A A A C T G G A T A A G A T 
^ MF979 
3 6 1 G A T G G A A T A T G A A T C G T C T T A G A A T C A A G C A T T A T C G A T A 
^ • 
vector sequence 
Sj 16 sequence 
4 0 1 C C G T C G A C C T C G A G G G G G G G C C C G G T A C C C 
Fig. 3.4. The nucleotide sequence of Sjl6 full-length cDNA (354 bp) and location 
of the gene specific primers : MF978/979. ABI Prism™ dRodamine Terminator 
Cycle Sequencing Ready Reaction Kit was used for cycle sequencing of pBluescript 
SK(-)/Sjl6. Gene specific primers : MF978/979 were used as sequencing primers and 
shown in shaded region. The Sjl6 full-length cDNA sequence was indicated by the 
arrows. 
77 
3.3 Analysis of Sjl6 Nucleotide and Amino Acid 
Sequence 
After the Sjl6 gene was sequenced. The Sjl6 full-length cDNA sequence was 
translated by translate tool available in the ExPASy (Expert Protein Analysis System) 
proteomics server of the Swiss Institute of Bioinformatics (SIB) 
(http://www.expasv.org/) (Fig 3.5). The translated amino acid sequence consists on 
117 amino acids. The sequence was aligned against different nucleotide or protein 
sequences databases available by using the Basic Local Alignment Search Tool 
(BLAST) in the United State National Center for Biotechnology Information (NCBI) 
(www.ncbi.nlm.gov). The similarities of the Sjl6 cDNA and amino acid sequences 
with different sequences were compared. The Sjl6 nucleotide sequence was analyzed 
by blastn aligning with other nucleotide sequences in the nr database (All GenBank, 
RefSeq Nucleotides, EMBL，DDBJ and PDB sequences (but no EST, STS，GSS, or 
phase 0, 1 or 2 HTGS sequences), the top three homologous sequences were shown 
(Fig.3.6). The translated amino acid sequence was analyzed by blastx to align with 
other amino acid sequences in the nr database (All non-redundant GenBank CDS 
translations, RefSeq Proteins, PDB, SwissProt, PIR and PRF), the top two 
homologous sequences were shown (Fig. 3.7). 
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ATG AAA GTG ACG CCA ATT ATC TTC GCT GTA TTT TGT GTC GTA GGT 
M K V T P I I F A V F C V V G 
G C T A T G A C A T T G A T C A C A G C T A C A A C G T T A G A G C A A G C A C C T C A C 
A M T L I T A T T L E Q A P H 
C C G A G T G A A A A A G A C A T G G A A T T A G T G T A T A T T G A T G C A G A A T A T 
P S E K D M E L V Y I D A E Y 
G A A A A A G A A G G T G G A C T G A A A T C A A T A T G C A A C G A A A T A A A A C G G 
E K E G G L K S I C N E I K R 
T C A T T C A G A A A A G G G C G C C A C C A C A T C T A T A A A G T T A T G G A T A A A 
S F R K G R H H I Y K V M D K 
T A T A T A C G G A A G G A A G A T T T A G G C A T G A A A A T G T T A G A T G T T G C C 
Y I R K E D L G M K M L D V A 
A A A A T C C T T G G A A G A C G C A T T G A A A A A C G T A T G G A A T A G A T A G C G 
K I L G R R I E K R M E Y I A 
AAG AAA CTG GAT AAG ATG ATG GAA TAT GAA TCG TCT TAG 
K K L D K M M E Y E S S -
Fig. 3.5. The translated amino acid sequence of Sjl6 (117 aa). The nucleotide 
sequence of Sj 16 was translated into amino acid sequence by translation tool available 
in The ExPASy (Expert Protein Analysis System) proteomics server of the Swiss 
Institute of Bioinformatics (SIB) fhttp://www.expasv.org/). The translated amino acid 
sequence is of 117 amino acids. The start codon : ATG and the stop codon : TAG were 
shown in bold. 
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3.3.1 Blastn Search Analysis 
The top three homologous sequences were shown below : 
Sequences producing significant alignments : Score (Bits) E Value 
1. g i l 4 5 9 0 3 4 1 | g b l A F 1 0 9 1 8 0 . 1 | A F 1 0 9 1 8 0 Schistosoma mansoni s tage-speci f ic 702 0.0 
2. g i l 3641362 lgb iAF091509 .1IAF091509 Schistosoma mansoni stathmin-like.. . 702 0.0 
3. g i | 8 4 6 8 6 1 2 | g b l A F 2 6 9 2 5 2 . 1 | A F 2 6 9 2 5 2 Schistosoma mansoni anti-inflammatory ^ l e - 1 4 5 
1. gi |4590341|gblAF109180.1IAF109180 Schistosoma mansoni stage-specific protein SPO-1 (SPO-1) 
mRNA, complete cds 
Length=511 Score = 702 bits (354)，Expect = 0.0 
Identities = 354/354 (100%), Gaps = 0/354 (0%) Strand=Plus/Plus 
Query 1 A T G A A A G T G A C G C C M m T C T T C G C T G T A r n T G T G T C G T A G G T G C T A T G A C A r T G A T C 60 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIMIIIIIilll 
Sbjct 30 A T G A M G T G A C G C C M T T A T O T C G C T G T A T n T G T G T C G T A G G T G C T A T G A C A T T G A T C 89 
Query 61 A C A G C T A C M C G m G A G C M G C A C C T C A C C C G A G T G A A A A A G A C A T G G A A T T A G T G T A T 120 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I i I I I I I I I I I M 
Sbj c t 90 A C A G C T A C A A C G m G A G C M G C A C C T C A C C C G A G T G A A A A A G A C A T G G M T T A G T G T A T 149 
Query 121 A T T G A T G C A G M T A T G A A A M G M G G T G G A C T G A M T C M T A T G C M C G A A A T A A A A C G G 180 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I M I I 
Sbjct 150 ATTGATGCAGMTATGAAAMGMGGTCXJACTGAAATCAATATGCAACGAAATAAAACGG 209 
Query 181 TCATTCAGAAMGGGCGCCACCACATCTATAMGTTATGGATAAATATATACGGMGGAA 240 
1 I I I I I I I I I I I I I I I I I I I I I I I I i I I I I I I I I I I I I I I I I I M I I I I I I I I I I I I I I I 
Sbjct 210 TCATTCAGAAMGGGCGCCACCACATCTATAAAGTTATGGATAMTATATACGGMGGM 269 
Query 241 G A T m G G C A T G A A A A T G m G A T G T T G C C A M A T C C T T G G A A G A C G C A T T G A A A M C G T 300 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I M I I I I I I 
Sbjct 270 G A n T A G G C A T G A A M T G T T A G A T G T T G C C A A M T C C r r G G M G A C G C A T r G A A A A A C G T 329 
Query 301 ATGGMTACATAGCGMGAMCTGGATAAGATGATGGAATATGAATCGTCTTAG 354 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I M I I I I I I 
Sbjct 330 ATGGMTACATAGCGMGAMCTGGATMGATGATGGMTATGMTCGTCTTAG 383 
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2. g i |3641362 |gb |AF091509.1 |AF091509 Schistosoma mansoni stathmin-like protein (SLP) mRNA, 
complete cds 
Length=500 Score 二 702 bits (354), Expect 二 0.0 
Identities = 354/354 (100%), Gaps = 0/354 (0%) Strand=Plus/Plus 
Query 1 A T G A M G T G A C G C C M m T C n C G C T G T A T m G T G T C G T A G G T G C T A T G A C A T T G A T C 60 
I I I I I I I I I I I I I I I M M I I I I I I M I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct 14 ATGAAAGTGACGCCAATTATCTTCGCTGTATnTGTGTCGTAGGTGCTATGACATTGATC 73 
Query 61 A C A G C T A C M C G m G A G C M G C A C C T C A C C C G A G T G A A A A A G A C A T G G A A T T A G T G T A T 120 
I I I I I I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I M M I I I I M I I I I I I I 
SbjCt 74 A C A G C T A C M C G T T A G A G C A A G C A C C T C A C C C G A G T G M A A A G A C A T G G M T T A G T G T A T 133 
Query 121 A T T G A T G C A G M T A T G A M A A G M G G T G G A C T G A A A T C A A T A T G C M C G A A A T A A A A C G G 180 
I I I I ! I I I I I I I I I I I I I I I I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I M 
Sbjct 134 ATTGATGCAGAATATGAAAAAGMGGTGGACTGAMTCMTATGCAACGAAATAAAACGG 193 
Query 181 TCATTCAGAAAAGGGCGCCACCACATCTATAMGTTATGGATMATATATACGGMGGAA 240 
II m m 11 丨丨 I 丨 I 丨 III I 丨 m 11M11 丨 I 丨 M I m III 丨 M I m M M 1 1 1 m I 
Sbjct 194 TCATTCAGAAMGGGCGCCACCACATCTATMAGTTATGGATAMTATATACGGAAGGAA 253 
Query 241 G A T T T A C m T G A M A T G m G A T G T T G C C M A A T C C r r G G M G A C G C A T T G A A A A A C G T 300 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I M 
Sbjct 254 GAnTAGGCATGAAAATGTTAGATGTTGCCAAMTCCTrGGAAGACGCATTGMAAACGT 313 
Query 301 ATGGAATACATAGCGAAGAAACTGGATAAGATGATGGAATATGAATCGTCTTAG 354 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I M I I I I I I I I I I 
Sbjct 314 ATGGMTACATAGCGMGAMCTGGATAAGATGATGGAATATGAATCGTCTTAG 367 
3. gi |8468612 |gblAF269252.1|AF269252 Schistosoma mansoni anti-inflammatory protein 16 mRNA, 
partial cds 
Length=397 Score = 523 bits (264), Expect 二 le-145 
Identities = 264/264 (100%), Gaps = 0/264 (0%) Strand=Plus/Plus 
Query 91 CCGAGTGAAAAAGACATGGAATTAGTGTATATTGATGCAGAATATGAAAAAGAAGGTGGA 150 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct 1 CCGAGTGAAAAAGACATGGAATTAGTGTATATTGATGCAGAATATGAAAAAGMGGTGGA 60 
81 
Query 151 CTGAAATCAATATGCAACGAAATAAAACGGTCATTCAGAAMGGGCGCCACCACATCTAT 21 〇 
I I I I I I I I I I M I I I I I I I M M I I M I I I M I I 11 I 11 I I I I I I I I I I I I I I I I I I I M 
Sbjct 61 CTGAAATCAATATGCAACGAAATAAAACGGTCATTCAGAAMGGGCGCCACCACATCTAT 120 
Query 211 AAAGTTATGGATAAATATATACGGAAGGAAGAnTAGGCATGAMATGrTAGATGTTGCC 270 
111111 丨 m 11 m IMIMI 丨 m IMI m I m m 11 III 111 m 1111 丨 1111 
Sbjcr 121 AAAGTTATGGATAAATATATACGGAAGGAAGATTTAGGCATGAAAATGTTAGATGrrGCC 180 
Query 271 AAAATCCTTGGMGACGCATTGAAAAACGTATGGAATACATAGCGAAGAAACTGGATAAG 330 
I I I I I I I I I I I I I I I I I II M I I I I I I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct 181 AAAATCCTTGGAAGACGCATTGAAAAACGTATGGAATACATAGCGAAGAAACTGGATAAG 240 
Query 331 ATGATGGAATATGAATCGTCTTAG 354 
I I I I I I I I I I I I I I I I I I II I I I I 
Sbjct 241 ATGATGGAATATGAATCGTCTTAG 264 
Fig. 3.6. The Blastn search results of aligning the Sjl6 nucleotide sequence with 
the nr database. The Blastn search results showed the three genes in Schistosoma 
mansoni that have the highest scores in sequence alignment with Sjl6 gene against the 
nr nucleotide sequences database. 
3.3.2 Blastx Search Analysis 
The top two homologous sequences were shown below : 
Sequences producing significant alignments: Score (Bits) E Value 
1 . g i | 4 5 8 8 4 8 3 | ^ b | A A D 2 6 1 2 2 . 1 | S P O - 1 p r o t e i n [Schistosoma mansoni]... 2 3 4 4 e - 6 1 
2. gi l84686]3ltTh |AAF75550 .1| anti-inflammatory protein 16 [Schistosoma mansoni] 176 l e -43 
1. gi|4588483|{^h| AAD26122. i l SPO-1 protein [Schistosoma mansoni] 
gi |4590342 |{^h|AAD26535.il stage-specific protein SPO-1 [Schistosoma mansoni] 
gi |3641363|^b|AAC36363.] | stathmin-like protein [Schistosoma mansoni] 
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Length=117 S c o r e : 234 bits (598)，Expect = 4e-61 
Identities = 117 /117(100%), Positives = 1 1 7 / 1 1 7 ( 1 0 0 % ) , Gaps = 0/117 (0%) Frame 二 +1 
Query 1 MKVTPIIFAVFCWGAMTLITATTLEQAPHPSEKDMELVYIDAEYEKEGGLKSICNEIKR 180 
MKVTPIIFAVFCWGAMTLITATTLEQAPHPSEKDMELVYIDAEYEKEGGLKSICNEIKR 
Sbjct 1 MKVTPIIFAVFCWGAMTLITATTLEQAPHPSEKDMELVYIDAEYEKEGGLKSICNEIKR 60 
Query 181 SFRKGRHHIYKVMDKYIRKEDLGMKMLDVAKILGRRIEKRiMEYIAKKLDKMMEYESS 351 
SFRKGRHHIYKVMDKYIRKEDLGMKMLDVAKILGRRIEKRMEYIAKKLDKMMEYESS 
Sbjct 61 SFRKGRHHIYKVMDKYIRKEDLGMKMLDVAKILGRRIEKRMEYIAKKLDKMMEYESS 117 
2. gi |8468613|gblAAF75550.1| anti-inflammatory protein 16 [Schistosoma mansoni] 
Length=87 Score 二 176 bits (447), Expect = le-43 
Identities = 87/87 (100%), Positives = 87/87 (100%), Gaps = 0/87 (0%) Frame = +1 
Query 91 PSEKDMELVYIDAEYEKEGGLKSICNEIKRSFRKGRHHIYKVMDKYIRKEDLGMKMLDVA 270 
PSEKDMELVYIDAEYEKEGGLKSICNEIKRSFRKGRHHIYKVMDKYIRKEDLGMKMLDVA 
Sbjct 1 psekdmelvyidaeyekegglksicneikrsfrkgrhhiykvmdkyirkedlgmkmldva 60 
Query 271 KILGRRIEKRMEYIAKKLDKMMEYESS 351 
KILGRRIEKRMEYIAKKLDKMMEYESS 
Sbjct 61 KILGRRIEKRMEYIAKKLDKMMEYESS 87 
Fig. 3.7. The Blastx search results of aligning the Sjl6 nucleotide sequence with 
the nr database. The Blastx search results showed the two peptide sequences in 
Schistosoma mansoni that have the highest scores in sequence alignment with Sjl6 
translated sequence against the nr peptide sequences database. 
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3.3.3 Structural Analysis 
From the ExPASy (Expert Protein Analysis System) proteomics server of the 
Swiss Institute of Bioinformatics (SIB), there are a number of proteomic tools 
available to analyze the protein structure. The primary structure analysis computed the 
isoelectric point (pi) and molecular weight (MW) of Sjl6. The computed pi of Sjl6 is 
9.02 and the MW is 13651.2 (Table 3.1). Signal? was used to predict the signal 
peptide cleavage sites of Sjl6, the resulted showed that Sjl6 has a cleavage site 
between amino acids position 16-17 based on the neural networks (NN) (Fig. 3.8) and 
a cleavage site between positions 22-23 based on hidden Markov models (HMM) (Fig. 
3.9). TMpred program was used to predict the transmembrane regions and orientation 
of Sjl6. The strongly preferred model suggested that the N-terminus inside with one 
transmembrane region (Fig. 3.10). 
The above analysis suggested that Sjl6 has a high probability of having a 
transmembrane region and a signal peptide cleavage site at the N-terminus, so the 
Sjl6 protein is strongly believe to be a secretory protein. 
Table 3.1. The computed isoelectric point (pi) and molecular weight (MW) of 
Sjl6. 
Number of amino acids translated 117 
*Theoretical isoelectric point (pi) 9.02 
*Molecular weight (MW) 13651.2 
* The pi and MW are computed from the software available in ExPASy 
84 
S i gna1P-NM prediction C euk network s>： Sequence 
I 1 1 1 1 1 1 C score ^ ‘ ® _ —-V S score — “ Y score 
0 . 8 " V \ • 
0.6 - \ _ 
a. \ % \ 
£ 0-4 - \ -
… A -
0.0 , III I I I I • � � — 」 ： - � 
MKV TP I IFAVFCVVGAMTL ITATTLEQAPHPSEKDMELVYIDAEYEKEGGLKSICNEI KRSFRKGRHHI" 
1 1 1 1 I I 
0 10 20 30 40 58 60 70 
Pos11 i on 
>Sequence length = 70 
# Measure Position Value Cutoff signal peptide? 
max. C 17 0.357 0.32 YES 
max. Y 17 0.378 0.33 YES 
max. S 14 0.994 0.87 YES 
means 1-16 0.942 0.48 YES 
D 1-16 0.660 0.43 YES 
# Most likely cleavage site between pos. 16 and 17: VGA-MT 
Fig. 3.8. Signal-NN (Neural Network) result from Signal? analysis of the Sjl6 
translated sequence . It showed that Sjl6 has a high probability of having a signal 
peptide between the amino acid position 16 and 17. 
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SignalP-HMM prediction <euk models)： Sequence 
I 1 1 1 1 1 1 Cleayage prob, 一/\ , — n-reg i on prob. 
/ \ h-reg i on prob. 
、、 广 \ c - r e g lot, p r o h. 
0 . 8 - 1 / \ -
1/ V ！ 
0 . 6 - ！ \ -
a- 1 t. ‘ f, 
^ - / i -
： : A . . A j x ———___ 二 
MKVTPIIFAVFCVVGAMTLITATTLEQAPHPSEKDMELVYIDAEYEKEGGLKSICNEIKRSFRKGRHHI"' 
1 1 1 I I I 
0 10 20 38 40 50 60 ？0 
Posi-tion 
>Sequence 
Prediction: Signal peptide 
Signal peptide probability: 0.952 
Signal anchor probability: 0.046 
Max cleavage site probability: 0.607 between pos. 22 and 23 
Fig. 3.9. Signal-HMM (hidden Markov model) result from SignalP. It showed that 
Sj 16 has a high probability of having a signal peptide between the amino acid position 
22 and 23. 
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2 possible models considered, only significant TM-segments used 
> STRONGLY preferred model: N-terminus inside 
1 strong transmembrane helices, total score : 2305 
# from to length score orientation 
1 3 21 (19) 2305 i-o 
> alternative model 
1 strong transmembrane helices, total score : 2155 
# from to length score orientation 
1 3 21 (19) 2155 o-i 
TMpr^ed output for unknown 
3900 I 1 1 1 1 I . 、 I 
1 - � � 
2900 - -
f \ 
1900 - “ 
3 
\ _ 
- 1 0 0 9 - •； \ 
\ 
- 2 0 0 0 - -
：：： ， -
I I I I I -6000 ‘ ‘ ‘ 
0 20 40 60 89 100 120 
Fig. 3.10. The TMpred program predicted transmembrane region and the 
orientation of Sjl6. The strongly preferred model suggested that Sjl6 N-terminus is 
inside with one transmembrane region. 
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3.4Subcloning of Sjl6 cDNA into pET30a+ and 
pSecTag2B Expression Vector 
After the Sjl6 full-length cDNA was cloned into the cloning vector, pBluescript 
II SK(-); the Sjl6 cDNA was further subcloned into different expression vector to 
express the recombinant protein in different expression system. The Sj 16 cDNA was 
subcloned into pET30a+ vector for bacterial cell expression of the recombinant 
protein. Also, Sjl6 cDNA was subcloned into pSecTag2B vector for mammalian cell 
expression of the recombinant protein. The outline of constructing pET30a+/Sjl6 and 
pSecTag2B/Sjl6 was shown (Fig.3.11). 
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丨 i 卜i. otiT^  X 
OMP.OLL N / / 
/ / \ 
pBluescript liSKH/Sjie Bsiie 
\
^pjoc Sjl6 gene was cut out 
--―：^^ from pBluescript II 
P"''口 SK(-)/Sjl6 by EcoRI 
and Xhol restriction 
n …，、—\ enzyme digestion. 
/ / i p ^ 咖 
pBluescript |SK(^ S|1« 
� ^ ^ 
pLK： on i 
5， 1 3 m m 
I I 
Z \ 
/ f ^ V ^ 广 V 
I j pET30a* W / / 1 ‘ \ � B ‘ 丨丨 pSecTag2B • _ _ 
\ � _ J P ™ a + a n d V / 
� — — - p S e c T a g 2 B were cut � � - — 
by EcoRI and Xhol. 
i T 
Ligation of Sjl6 夕 : � ~ % 
“PET30a./Sj16 ^ ^ 二 ^ gene with the �pSecT 明 f 
I j j f plasmid vector J T " 
using T4 ligase. . ^ 
Fig. 3. 11. Outline of the construction of pET30a+/Sjl6 and pSecTag2B/Sjl6. 
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1 C A C C A T C A T C A T C A T C A T T C T T C T G G T C T G G T G C C A C G C G G T 
4 3 T C T G G T A T G A A A G A A A C C G C T G C T G C T A A A T T C G A A C G C C A G 
8 5 C A C A T G G A C A G C C C A G A T C T G G G T A C C G A C G A C G A C G A C A A G 
Vector sequence Sjl6 (354bp) 
M • 
127 GCC ATG GCT GAT ATC GGA TCC |GAA TTC| GAT ATG AAA GTG ACG 
M K V T 
169 CCA ATT ATC TTC GCT GTA TTT TGT GTC GTA GGT GCT ATG ACA 
p I I F A V F C V V G A M T 
211 TTG ATC ACA GCT ACA ACG TTA GAG CAA GCA CCT CAC CCG AGT 
L I T A T T L E Q A P H P S 
2 53 GAA AAA GAC ATG GAA TTA GTG TAT ATT GAT GCA GAA TAT GAA 
E K D M E L V Y I D A E Y E 
295 AAA GAA GGT GGA CTG AAA TCA ATA TGC AAC GAA ATA AAA CGG 
K E G G L K S I C N E I K R 
337 TCA TTC AGA AAA GGG CGC CAC CAC ATC TAT AAA GTT ATG GAT 
S F R K G R H H I Y K V M D 
37 9 AAA TAT ATA CGG AAG GAA GAT TTA GGC ATG AAA ATG TTA GAT 
K Y I R K E D L G M K M L D 
421 GTT GCC AAA ATC CTT GGA AGA CGC ATT GAA AAA CGT ATG GAA 
V A K I L G R R I E K R M E 
463 TAC ATA GAG AAG AAA CTG GAT AAG ATG ATG GAA TAT GAA TCG 
Y I A K K L D K M M E Y E S 
Sjl6 (354bp) f T T " I , I 
J Vector sequence Xhol • 
501‘ TCT TAG ATC AAG CTT ATC GAT ACC GTC GAC |CTC GAG| CAC 
S -
Fig. 3.12. The nucleotide sequence of pET30a+/Sjl6. The nucleotide sequence of 
Sjl6 cDNA (354 bp) was shaded. The recognition sites for the restriction enzymes 
EcoRI and Xhol were squared. 
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EcoRI Sj 16 (3 54bp) 
Vector sequence 
^ ^ 
1 C T C G G A T C C A C T C C A G T G TG|G A A T T ^ G A T T A T G A A A G T G A C G 
M K V T 
4 3 C C A A T T A T C T T C G C T G T A T T T T G T G T C G T A G G T G C T A T G A C A 
P I I F A V F C V V G A M T 
8 5 T T G A T C A C A G C T A C A A C G T T A G A G C A A G C A C C T C A C C C G A G T 
L I T A T T L E Q A P H P S 
1 2 7 G A A A A A G A C A T G G A A T T A G T G T A T A T T G A T G C A G A A T A T G A A 
E K D M E L V Y I D A E Y E 
1 6 9 A A A G A A G G T G G A C T G A A A T C A A T A T G C A A C G A A A T A A A A C G G 
K E G G L K S I C N E I K R 
2 1 1 T C A T T C A G A A A A G G G C G C C A C C A C A T C T A T A A A G T T A T G G A T 
S F R K G R H H I Y K V M D 
2 5 3 A A A T A T A T A C G G A A G G A A G A T T T A G G C A T G A A A A T G T T A G A T 
K Y I R K E D L G M K M L D 
2 9 5 G T T G C C A A A A T C C T T G G A A G A C G C A T T G A A A A A C G T A T G G A A 
V A K I L G R R I E K R M E 
3 3 7 T A G A T A G A G A A G A A A C T G G A T A A G A T G A T G G A A T A T G A A T C G 
Y I A K K L D K M M E Y E S 
3 7 9 T C T T A G A A T C A A G C T T A T C G A T A G C G T C G A C | C T C G A G|GA G G G 
S -
^ ^ 
Sj 16 (354bp) Vector sequence 灿。丨 
Fig. 3.13. The nucleotide sequence of pSecTag2B/Sjl6. The nucleotide sequence of 
Sjl6 cDNA (354 bp) was shaded. The recognition sites for the restriction enzymes 
EcoRI and Xhol were squared. 
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3.5Expression of the rSjl6 
After Sjl6 cDNA was cloned into the expression vector. Sjl6 recombinant 
protein was expressed in the bacterial cell system and animal cell system, respectively. 
The expression using bacterial cells are fast and in large quantity, however, it lacks 
secondary modification of the expressed proteins. Using mammalian cells expression 
system can get over the modification problem, but the level of recombinant protein 
expression is much lower than that of the bacterial cells expression system. 
As Sjl6 is a protein expressed by the eukaryotic parasite, S. japonicum, the 
animal cell system expressed recombinant protein may be more alike with the 
naturally expressed Sjl6. So, the Sjl6 gene was subcloned into pET30a+ vector and 
pSecTag2B vector for expression with different purposes. The recombinant protein 
was successfully expressed in bacterial cell system, however, the recombinant protein 
expression in animal cell system could not be detected. 
3.5.1 Animal Cell Expression 
pSecTag2B/Sj 16 and pEGFP-Nl plasmids were co-transfected into COS-1 cells 
using DMIRE-C reagent (Invitrogen. Carlsbad, US), for the expression of 
recombinant protein in animal cells (materials and methods 2.2.3.1). The pEGFP-Nl 
plasmid encoded a green fluorescence protein, so the co-transfected cells gave 
fluorescence under UV exposure to indicate successful transfection (Fig. 3.14). The 
transfected cells were selected by G418 to establish a single, stable clone of 
pSecTag2B/Sjl6 and pEGFP-Nl co-transfected cell line. 
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Fig. 3.14. Pictures showed the untransfected and co-transfected COS-1 cells 
under the exposure of UV radiation. Picture A showed the control of untransfected 
COS-1 cells under UV radiation. Picture B showed the COS-1 cells co-transfected 
with pSecTag2B/Sjl6 and pEGFP-Nl plasmids under UV radiation. The 
co-transfected cells gave out green fluorescent under UV radiation. The cells were 
observed under 400 X magnification. 
3.5.1.1 Analysis of mRNA Transcript by RT-PCR 
The stably co-transfected clones were PCR screened with Sjl6 gene specific 
primers : MF980/981 (materials and methods 2.2.3.2). 4 out of 8 of the stably 
co-transfected clones were screened of having the recombinant plasmids (Fig. 3.15). 
RNA of the 4 stably co-transfected clones were isolated (Fig. 3.16) and RT-PCR was 
done with Sjl6 gene specific primers : MF980/981 (materials and methods 2.2.3.3). 
However, no bands could be amplified (Fig. 3.17). The transcription of the Sjl6 gene 
in the co-trasfected cells could not be detected. 
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M 1 2 3 4 5 6 7 8 
307 bp 
S H H I H 
Fig. 3.15. Gel electrophoresis of PGR screening of the stably co-transfected 
COS-1 cells. M : Ikb plus DNA ladder. Lane 1-8 : selected stably co-transfected 
clones. The arrow indicted the MF980/981 amplified band of 307 bp. 
M 1 2 3 4 
• M 
28S 
Fig. 3.16. Gel electrophoresis of the guanidinium thiocyanate-cesium chloride 
u n l t r a c e n t r i f u g a t i o n isolated total RNA of the 4 screened stably co-transfected 
clones. M : Ikb plus DNA ladder. Lane 1-4 : the 4 stably PGR screened 
co-transfected clone 2, 4, 5, 6 as shown in Fig. 3.15. 
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M 1 2 3 4 
307 bp imiiniiiiiiiiiiimiiiiiiiiiniiiii 
bp _^nmjjmjmjjmiujjui 
Fig. 3.17. Gel electrophoresis of RT-PCR of the isolated RNA of the 4 stably 
co-transfected clones. M : Ikb plus DNA ladder. Lane 1-4 : the 4 stably PGR 
screeened co-transfected clones 2，4，5, 6 as shown in Fig. 3.15. The arrow indicted 
the MF980/981 amplified band of 307 bp. The arrow indicted the GAPDH amplified 
band of 452 bp. 
3.5.1.2 Western Blot of Condition Medium 
The recombinant protein was expected to be secretory, so the co-transfected cells 
cultured medium (condition medium) was collected to analyze the recombinant 
protein expression. After 72 hours of incubation with the co-transfected cells, the 
condition medium was collected. After collected the condition medium, Western Blot 
was done to analyze expression of recombinant proteins using natural S. japonicum 
cercariae infected rabbit serum as primary antibody (materials and methods 2.2.3.5). 
The Western Blot result showed that the natural S. japonicum cercariae infected rabbit 
serum could not recognize any protein in the condition medium (Fig. 3.18). The 
condition medium contained the large molecular size fetal serum album that might 
affect the recognition of the anti-bodies with the target protein. Also, the level of 
recombinant protein expression in co-transfected COS-1 cells might be low. So, the 
large molecular size fetal serum album was removed by Centricon YM50 (Millipore, 
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Billerica, US). After removal of the fetal serum album, the recombinant proteins were 
concentrated using Microcon YMIO (Millipore, Billerica, US) (materials and methods 
2.2.3.4). Western Blot was done again to analyze the expression of the recombinant 
proteins using the S. japonicum infected rabbit serum. The Western Blot result showed 
that the S. japonicum infected rabbit serum could not recognize any protein in the 
concentrated condition medium (Fig. 3.19). The expression of the recombinant 
protein in animal expression system could not be detected. 
A - Western Blot ^ " Amido black staining 
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Fig. 3.18. Western Blot of COS-1 condition medium with natural S, japonicum 
cercariae infected rabbit serum. Picture A showed the Western Blot result. Picture B 
showed the amido black staining of the transblotted PVDF membrane. M : 
SDS-PAGE molecular weight standard, broad range. Lane 1 : untransfected COS-1 
cultured medium. Lane 2 : pEGFP-Nl transfected COS-1 cultured medium. Lane 3 : 
pSecTag2B and pEGFP-Nl co-transfected condition medium. The arrow indicated the 
size of about 16 kDa. 
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Fig. 3.19. Western Blot of concentrated COS-1 condition medium with natural 
S. japonicum cercariae infected rabbit serum. A showed the amido black staining 
of the transblotted PVDF membrane. B showed the Western Blot result. M : 
SDS-PAGE molecular weight standard, broad range. Lane 1 : untransfected COS-1 
cultured medium. Lane 2 : pEGFP-Nl transfected COS-1 cultured medium. Lane 3 : 
pSecTag2B and pEGFP-Nl co-transfected condition medium. The arrow indicated the 
size of about 16 kDa. 
3.5.1 Bacterial Cell Expression 
3.5.2.1 Optimization of rSjl6 Expression 
The pET30a+/Sjl6 plasmid was transformed into BL21, expression host to 
facilitate bacterial cell expression of recombinant proteins (materials and methods 
2.2.4.1). The optimal condition for recombinant protein expression was determined to 
be ImM IPTG for 3 hours induction and incubated at 37°C (Fig. 3.20) (materials and 
methods 2.2.4.2). 
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Fig. 3.20. SDS-PAGE showed the IPTG induced protein expression profile of 
pET30a+/Sjl6 transformed E. coli culture. Induction Period : 0.5, 1, 1.5, 2, 2.5，3, 
4 hours were indicated. M : the SDS-PAGE molecular weight standards, broad range. 
The two arrows indicated the molecular weight of 14.4 kDa and 6.5 kDa, respectively. 
The size of the inducible recombinant protein, Sj 16 is around 16 kDa. 
3.5.2.2 Estimation of rSjl6 Concentration 
The recombinant protein expression is inducible in the pET30a+/Sjl6 
transformed E. coli with a final concentration of ImM IPTG at 37°C for 3 hours. The 
quantity of recombinant protein expression was estimated by comparing the inducible 
band with the intensity of the BSA standard. The estimated level of expression of the 
recombinant protein was 0.15 mg/ml (Fig. 3.21) (materials and methods 2.2.4.4). 
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Fig. 3.21. SDS-PAGE showed the quantity of expression of recombinant protein 
compared with BSA standards. M : the SDS-PAGE molecular weight standards, 
broad range. Lane 1 : 10 )il of uninduced pET30a+/Sj 16. Lane 2 : 10 |il of induced 
pET30a+/Sjl6. Lane 3 - 9 : 10^1 of 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6 mg/ml BSA 
standard. The arrow indicated the inducible band about 16 kDa. 
3.5.2.3 Solubility of rSj 16 
The solubility and the exact location of the expressed recombinant protein was 
determined by analyzing the total bacterial protein; the inclusion body; and the pellet 
which contained the insoluble protein (materials and methods 2.2.4.3). The solubility 
of the recombinant protein was determined by the fraction that retained. The 
SDS-PAGE showed that the recombinant protein expressed was not retained in the 
inclusion body and was in the soluble protein fraction (Fig. 3.22). 
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Fig. 3.22. SDS-PAGE showed the protein content in different fractions of IPTG 
induced bacterial culture. M : the SDS-PAGE molecular weight standards, broad 
range. Lane 1 : uninduced pET30a+/Sjl6. Lane 2 : induced pET30a+/Sjl6. Lane 3 : 
inclusion body. Lane 4 : soluble protein fraction. The arrows indicated the inducible 
band about 16 kDa and the molecular weight of 21.5 kDa of the marker. 
3.5.2.4 Western Blot Analysis of rSjl6 
Recombinant Sjl6 protein was analyzed by Western Blot using the natural S. 
japonicum cercariae infected rabbit serum as primary antibody (materials and 
methods 2.2.4.5). The infected serum had antibodies that against S. japonicum 
secreted protein. The Western Blot result showed that the E. coli expressed 
recombinant Sjl6 protein could be recognized by the rabbit infected serum (Fig. 3.23). 
This implied that the recombinant protein is similar to a naturally expressed protein in 
S. japonicum during infection. 
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Fig. 3.23. The Western Blot showed the E, coli expressed recombinant Sjl6 could 
be recognized by the natural S. japonicum cercariae infected rabbit serum. The 
uninduced and induced bacterial culture were probed against the uninfected rabbit 
serum and natural S. japonicum cercariae infected rabbit serum, respectively. The 
arrow indicated the probed band of the induced culture with the S. japonicum infected 
rabbit serum at the size around 16 kDa. 
3.6 Purification of Recombinant Protein 
3.6.1 Purification of rSjl6 
pET30a+/Sjl6 expressed recombinant protein has a six histidine tag, the His 
bind purification kit (Novagen, Darmstadt, Germany) was used for specifically 
binding the his-tagged recombinant protein. Different washings were collected 
(materials and methods 2.2.5.1). SDS-PAGE of different fractions was shown in Fig. 
3.24. 
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Fig. 3.24. SDS-PAGE showed different fractions of his-tagged rSjl6 purified 
using the His bind purification kit. M : the SDS-PAGE molecular weight standards, 
broad range. Lane 1 : uninduced bacterial cell lysate. Lane 2 : Induced bacterial cell 
lysate. Lane 3 : clarified sample loaded into the affinity column. Lane 4 : equilibrium 
wash. Lane 5 : binding buffer wash. Lane 6 : wash buffer wash. Lane 7 : elution 
buffer wash. Lane 8 : strip buffer wash. Lane 9 : distilled water wash. The arrow 
indicated the band specifically eluted out was the same size as the inducible band at 
about 16 kDa. 
However, the elution buffer had high salt content that might affect the assay 
afterwards, the eluted recombinant protein was dialyzed against PBS using 
Slide-A-Lyzer (Promega, Madison, US) before carry out the assays in the later part 
(materials and methods 2.2.5.2) (Fig. 3.25). The protein concentration of different 
fractions was measured by the Bradford method using the Protein Assay Dye Reagent 
Concentrate (Bio-Rad, Hercules, US) using BSA as standard (Table 3.2) (materials 
and methods 2.2.5.3). 
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Fig. 3.25. SDS-PAGE showed the purified recombinant Sjl6 using the His bind 
kit and dialyzed using Slide-A-Lyzer. M : the SDS-PAGE molecular weight 
standards, broad range. Lane 1 : uninduced bacterial cell lysate. Lane 2 : Induced 
bacterial cell lysate. Lane 3 : clarified sample loaded into the affinity column. Lane 4 : 
elution buffer wash. Lane 5 : dialyzed recombinant protein in PBS. The arrow 
indicated the molecular weight about 16 kDa. 
Table 3.2. Protein yield of rSjl6 during each process of purification 
Sample Total volume Total volume got Concentration Total protein 
loaded (mg/ml) yield (mg) 
Elution from 40 ml clarified 150 ml elution 0.02 3 
affinity column sample from 1 L from 1 L 
bacterial culture bacterial culture 
Dialyzed 150 ml elution 40 ml dialyzed 0.05 2 
sample after from 1 L bacterial sample from 
Dialysis culture 150 ml elution 
For 1 L culture, the total protein yield after the affinity column was 3 mg; the total 
protein yield after dialysis was 2 mg, there was 33% lost. 
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3.6.2 Purification ofrSjCaS 
The recombinant Sjl6 was his-tagged, there may have argument that whether the 
presence of a his-tag may affect the functional assay. So, a his-tagged recombinant 
protein, SjCaS was purified to use as the control for a his-tagged protein. The 
molecular weight of recombinant SjCaS is around 20 kDa, similar to that of 
recombinant Sjl6. The pET30a+/SjCa8 was the generous gift from Miss Pecky Law. 
The optimal expression conditions for SjCaS are : ImM final concentration of IPTG, 
induced for 4 hours at 37�C. 
pET30a+/Sjl6 expressed recombinant protein has a six histidine tag, the His bind 
purification kit (Novagen, Darmstadt, Germany) was used for specifically binding the 
his-tagged recombinant protein. Different washings were collected (materials and 
methods 2.2.5.1). SDS-PAGE of different fractions was shown in Fig. 3.26. The 
eluted recombinant protein was dialyzed against PBS using Slide-A-Lyzer (Promega, 
Madison, US) before carry out the assays in the later part (materials and methods 
2.2.5.2) (Fig. 3.27). The protein concentration of different fractions was measured by 
the Bradford method using the Protein Assay Dye Reagent Concentrate (Bio-Rad, 
Hercules, US) using BSA as standard (Table 3.3) (materials and methods 2.2.5.3). 
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Fig. 3.26. SDS-PAGE showed the different fractions of his-tagged rSjCaS 
purified using the His bind purification kit. M : the SDS-PAGE molecular weight 
standards, broad range. Lane 1 : uninduced bacterial cell lysate. Lane 2 : Induced 
bacterial cell lysate. Lane 3 : clarified sample loaded into the affinity column. Lane 4 : 
equilibrium wash. Lane 5 : binding buffer wash. Lane 6 : wash buffer wash. Lane 7 : 
elution buffer wash. Lane 8 : strip buffer wash. Lane 9 : distilled water wash. The 
arrow indicated the band specifically eluted out was the same size as the inducible 
band at about 16 kDa. 
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Fig. 3.27. SDS-PAGE showed the purified recombinant SjCaS using the His bind 
kit and dialyzed using Slide-A-Lyzer. M : the SDS-PAGE molecular weight 
standards, broad range. Lane 1 : uninduced bacterial cell lysate. Lane 2 : Induced 
bacterial cell lysate. Lane 3 : clarified sample loaded into the affinity column. Lane 4 : 
elution buffer wash. Lane 5 : dialyzed recombinant protein in PBS. The arrow 
indicated the molecular weight about 16 kDa. 
Table 3.3. Protein yield of rSjCaS during each process of purification. 
Sample Total volume loaded Total volume got Concentration Total protein 
(mg/ml) yield (mg) 
Elution from 8 ml clarified 30 ml elution 0.025 0.75 
affinity column sample from 200 ml from 200 ml 
bacterial culture bacterial culture 
Dialyzed 30 ml elution from 8 ml dialyzed 0.040 0.32 
sample after 200 ml bacterial sample from 
Dialysis culture 30 ml elution 
For 200 ml bacterial culture, total protein yield after the affinity column was 0.75 mg; 
the total protein yield after dialysis was 0.32 mg, there was 57% lost. 
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3.7 Anti-inflammatory Activity of rSjl6 
3.7.1 Analysis of PECs in Thioglycollate Induced 
Inflammation 
Nine, eight weeks old female balb/c mice were used, three for each group : control : 
PBS, rSjCaS, treatment : rSjl6. The mice were injected with different sample and then 
3% thioglycollate into the peritoneal cavity (materials and methods 2.2.6.1). The 
peritoneal eluted cells were harvested for analysis. 
The total peritoneal eluted cells (with macrophage and other cell populations), 
non-adherent and the adherent macrophages (the highly differentiate immune cells) 
were counted respectively (Table 3.4). The number of total peritoneal eluted cells and 
adherent macrophages in the control groups were compared against the treatment 
group. By one-way ANOVA analysis, the total number of PECs in rSjl6 treated group 
is significantly less than the PBS control group with P-value less than 0.01. This 
showed that rSjl6 can suppress the thioglycollate induced immune recruitment during 
inflammation. The percentage of non-adherent cells in rSjl6 treated group is 
significantly more than the PBS control group with P-value less than 0.01. This 
showed that the PECs of rSjl6 treated mice contained higher proportion of 
undifferentiated immune cells, that is rSjl6 can suppress the differentiation of 
immune cells with the stimulation of inflammatory response (Fig. 3.28). 
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Table 3.4. Table showed the cells count for total peritoneal eluted cells (PECs), 
adherent cells and non-adherent cells treated with PBS, rSjCaS and rSjl6. 
Total PEC Total adherent cells Total non-adherent cells 
PBS-1 3.47 X10' 3.44x10' 3.39 x 10^  
PBS -2 3.54 X 10' 3.51 x 10' 3.21 x 10^  
PBS -3 3.50 X 10^  3.47 x 10' 3.15x10^ 
rSjCaS - 1 3.28 x 10^  3.25 x 10^  3.19x10^ 
rSjCaS - 2 3.34 x 10^  3.31 x 10^  3.22 x 10^  
rSjCaS - 3 3.42 x 10^  3.39 x 10^  2.98 x 10^  
rSjl6 - 1 8.46 x 10' 7.82 x 10' 6.44 x 10^  
rSjl6 - 2 8.57 x 10^  7.94 x 10' 6.29 x 10^  
rSjl6 - 3 8.43 x 10^  7.79 x 10' 6.40 x 10^  
The result showed that there was about 40% decrease of the total peritoneal eluted 
cells in the rSjl6 treated group when compared with the PBS control group and the 
rSjCaS treated group. Also, there was about 40% decrease in the number of adherent 
macrophages in the rSjl6 treated group when compared with the PBS control group 
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Fig. 3.28. The graphs showed the analysis of cell populations of adherent and 
non-adherent cells in total peritoneal eluted cells. The total PECs in rSj 16 treated 
group was significantly less than the PBS or rSjCaS treated group. Also, the 
non-adherent cells in rSjl6 treated group was significantly more than the PBS or 
rSjCaS treated group. 
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3.7.2 Hemacolor Staining ofPECs 
Cytospin was done by using the Hemacolor rapid staining kit (Merck, Darmstadt, 
Germany) to stain cells, nuclei were stained red and cytoplasm were stained light blue 
(materials and methods 2.2.6.2). The morphology of the cells was observed. The 
result showed that the cell count for the treatment group is lower than the control 
group. In control groups, the cells had lobed nuclei and dense cytoplasm; in treatment 
group, the cells had round and large nuclei (Fig. 3.29). For PBS or rSjCaS control 
groups, the cells are highly differentiated with lobed nuclei and dense cytoplasm. For 
rSjl6 group, the cells were undifferentiated had round and large nuclei. 
3.7.3 FACS analysis ofPECs 
The distribution of different peritoneal eluted cells population were analyzed by 
flow cytometry on forward scatter (FSC) and side scatter (SSC). The forward scatter is 
proportional to the diameter of the cells, the side scatter is proportional to the granularity. 
Different cell populations have different FSC and SSC values. The result showed that in 
the control groups, there were more differentiated immune cells (large and high 
granularity) than the treatment group (smaller size and lower granularity) (Fig. 3.30). 
The PECs of the rSjl6 treated mice contained large proportion of 
undifferentiated lymphocytes compared to controls. So, rSjl6 can suppress the 
thioglycollate stimulated inflammatory response by suppressing the differentiation 
and recruitment of lymphocytes. 
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Fig. 3.29. The pictures of the Hemacolor stained cells of PBS, rSjCaS or rSjl6 
treatment. The nuclei were stained with red color and the cytoplasm was stained with 
light blue color. The cells were observed under 400 X magnification. 
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Fig. 3.30. Flow cytometry on forward scatter (FSC) and side scatter (SSC) 
showed the distribution of different peritoneal eluted cells population. The 
percentage of cell population of larger size and denser granularity in the PBS or 
rSjCaS treated was higher than rSjl6 treated. 
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3.7.4 RT-PCR of RNA Isolated from PECs 
The peritoneal epithelial tissue of the treated mice were removed, total RNA was 
isolated by TRIZOL reagent (Invitrogen, Carlsbad, US) and by RT-PCR, the cytokines 
expression profile was studied (materials and methods 2.2.6.4). The result showed that 
there was no detectable expression of the cytokines : IL-la, IL-lra, Q-fms. Expression 
of IL-1 p, MCP-5, M-CSF, RANTES could be detected (Fig. 3.31). 
IL- la and IL-1 (3 are pro-inflammatory cytokines; IL-lra is the anti-inflammatory 
cytokine. MCP-5 and RANTES are chemokines that attract immune cells 
chemotactically; M-CSF is macrophage-colony stimulating factor to stimulate the 
differentiation and recruitment of macrophages, c-fms is the receptor for M-CSF. 
The result may suggested that PBS and rSjCaS could induce the inflammatory 
response by stimulating the expression the cytokines : IL-lp, MCP-5, RANTES， 
M-CSF. However, the expression of these cytokines could not be detected or 
expressed in low level in rSjl6 treated cells, may implied that rSjl6 cannot stimulate 
the inflammatory response. 
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Fig. 3.31. Gel electrophoresis of the RNA extracted from peritoneal epithelial 
tissue and the RT-PCR for the differential expression of different cytokines. M : 
Ikb plus DNA ladder. Lanes : PBS 1-3 were the samples treated with PBS. Lanes : 
rSjCa8 1-3 were the samples treated with rSjCaS. Lanes : rSjl6 1-3 were the samples 
treated with rSjl6. There was no detectable expression of IL-la and IL-lra, c-fms. 
There was detectable expression of IL-1 p，MCP-5, M-CSF, RANTES. 
116 
3.8 Immunogenicity and Antigenicity of rSjl6 
Immunogenicity of a particular substance is its ability to or the degree to provoke 
an immune response. Antigenicity is the ability of a molecule to stimulate the 
production of antibodies. The mice were immunized with the recombinant Sjl6 to 
assess the immunogenicity of Sjl6 to raise antibodies. Also, antigenicity of Sjl6 was 
tested by the recognition of Sjl6 by the Schistosoma japonicum infected rabbit serum 
using Western Blot. 
3.8.1 Immunogenicity of rSjl6 
The ability of the rSjl6 to raise antibodies against it, balb/c mouse were 
immunized with the recombinant Sjl6. The serum collected after immunization was 
probed against the recombinant Sjl6 (materials and methods 2.2.7.2; materials and 
methods 2.2.7.3). The result showed that the recombinant Sjl6 is immunogenic, it has 
the ability to stimulate the mouse to raise antibodies against it (Fig. 3.32). 
3.8.2 Antigenicity of rSjl6 
Sjl6 is believed to be a secretory protein. So, the natural S. japonicum cercariae 
infected rabbit serum may have an antibody that can recognize natural secreted Sjl6, 
this was checked by Western Blot (materials and methods 2.2.7.1). The ability of the 
natural S. japonicum infected rabbit serum to recognize the rSjl6 showed that the 
rSjl6 has a high specificity with the natural S. japonicum cercariae infected rabbit 
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serum. However, the UV irradiated S. japonicum cercariae infected rabbit serum did 
not have the ability to recognize rSjl6. The UV irradiated S. japonicum cercariae may 
have lost the ability to secrete Sjl6 to raise antibodies against it, as the protein 
production machinery in the attenuated parasite may be impaired (Fig. 3.33). The 
attenuated parasite may not be able to secrete the anti-inflammatory protein, it 
stimulates the host-parasite interaction more vigorously. 
M uninduced induced 
Fig. 3.32. The Western Blot showed that the E. coli expressed recombinant Sjl6 
protein can be recognized by the anti-Sjl6 antibodies raised in immunized mice. 
M : SDS-PAGE molecular weight standard, broad range, uninduced : ininduced 
pET30a+/Sjl6. induced : induced pET30a+/Sjl6. A band was probed specifically in 
the induced sample with the rSjl6 immunized mice anti-serum. 
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Fig. 3.33. The Western Blot result showed that the bacterial expressed Sjl6 was 
probed by the natural S. japonicum cercariae infected rabbit serum. M : 
SDS-PAGE molecular weight standard, broad range. pET30a+/Sjl6 transformed 
bacterial culture without (u) or with (i) IPTG induction were used to prepare protein 
samples. lOjil SDS-treated bacterial samples were separated on SDS-PAGE and 
blotted to PVDF membrane to perform Western Blot as described in materials and 
methods 2.2.7.1. The membrane strip was probed with normal rabbit serum (NRS), 
natural S. japonicum cercariae infected rabbit serum (IRS) or irradiated S. japonicum 
cercariae infected rabbit serum (UVRS). 
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3.9 Inhibitory Effect of rSjl6 on MuIFN-a4 Induced 
Up-regulation ofMHC(I) Expression 
The level of expression on the surface antigen : MHC (I) of JCS cells was 
measured by flow cytometry. Recombinant MuIFN-a4 is a generous gift from Mr. 
Lawrence Tsang. He had proved that MuIFN-a4 has the ability to induce the 
up-regulation of MHC (I) cell surface antigen. 
3.9.1 Time Course of rMuIFN-a4 Induced Up-regulation ofMHC(I) 
Expression 
The optimal time for MHC (I) up-regulation by rMuIFN-a4 was determined as 
described in materials and methods 2.28. It is the reference time point for later assays. 
The result showed that the optimal time for MHC (I) up-regulatory effect was 48 hrs 
of incubation, further increase of incubation time had no further up-regulatory effect 
on MHC (I) (Fig. 3.34). 
3.9.2 Inhibitory Effect of rSjl6 on MuIFN-a4 Induced MHC (I) 
Up-regulation 
The inhibitory effect of Sjl6 on the MuIFN-a stimulated MHC (I) up-regulation 
in JCS cells was measured by the FACS machine(materials and methods 2.2.8). The 
result showed that the recombinant Sjl6 had the ability to inhibit the up-regulatory 
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Fig. 3.34. Flow cytometery result showed the cells stained by FITC-conjugated 
anti-mouse antibody (MHC (I) specific) at different time point of 
rMuIFN-a4 induction. The JCS surface MHC (I) expression was studied with 
different rMuIFN-a4 incubation period. Cell control without FITC-conjugated 
antibodies incubation ( ). Cell control with FITC-conjugated antibodies 
incubation (——).Samples incubated with MuIFN-a4 for different time period and 
incubated with FITC-conjugated antibodies (……).With the up-regulation of MHC (I) 
on JCS cell surface, the peak will shift to the right. rMuIFN-a4 can up-regulate the 
MHC (I) expression as the peak shift towards the left. The peak shifted more 
prominent after 48 hours of stimulation. With longer time of incubation, the degree of 
shifting was similar. 
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Fig. 3.35. Flow cytometery result showed the cells stained by FITC-conjugated 
anti-mouse H-2Kd antibody (MHC (I) specific) with different treatment. It 
showed that the recombinant Sjl6 had the ability to inhibit the up-regulatory effect of 
rMuIFN-a4 on MHC (I) expression, but not the his-tagged rSjCaS. Cell control 
without FITC-conjugated antibodies incubation ( ). Cell control with 
FITC-conjugated antibodies incubation (——).Samples incubated under different 
conditions and incubated with FITC-conjugated antibodies ( ). 
3.9.3 Anti-proliferation Effect of rMuIFN-a4, rSjl6 and rSjCaS 
The anti-proliferation effect of rSjl6 and rSjCaS was studied by the Cell 
Proliferation ELISA, BrdU (colorimetric) kit (Roche, Mannheim, Germany) as 
described in materials and methods 2.2.9. The reaction product was quantified by 
measuring the absorbance at 370 nm using the ELISA reader. The absorbance values 
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are directly correlated to the amount of DNA synthesis and to the number of 
proliferating cells. The data were analyzed with the GraphPad Prism 4 software. The 
result showed that rSjl6 and rSjCaS did not have anti-proliferation effect on JCS cells 
(Fig. 3.36). rMuIFN-a4 has the anti-proliferative effect on JCS cells. 
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Fig. 3.36. Analysis of the anti-proliferation effect of rSjCaS, rSjl6，rMuIFN-a4 
using BrdU kit. rSjCaS, rSjl6 have no anti-proliferative effect on JCS cells. 
rMuIFN-a4 has anti-proliferative effect on JCS cells. 
3.9.4 Effect of Signal Transduction Inhibitors on MuIFN-a4 Induced 
MHC (I) Up-regulation 
Three signal transduction inhibitors : PD169316, PD98059, SB203580 in the 
presence or without rMuIFN-a4 were used to study which signal pathway 
rMuIFN-a4 has effect on (materials and methods 2.2.8). The result showed that the 
three signal transduction inhibitors had no effect of rMuIFN-a4 stimulated MHC (I) 
up-regulation, so the up-regulation was not through these pathways (Fig. 3.37). 
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Fig. 3.37. Flow cytometery result showed the cells stained by FITC-conjugated 
anti-mouse U-IK^ antibody (MHC (I) specific) with different signal transduction 
inhibitors. It showed that the three signal transduction inhibitors : PD169316， 
PD98059, SB203508 tested did not inhibit the up-regulatory effect of rMuIFN-a4 on 
MHC (I) expression. So the effect of rMuIFN-a4 was not through this transduction 
pathway. Cell control without FITC-conjugated antibodies incubation ( ). Cell 
control with FITC-conjugated antibodies incubation (……).Samples incubated under 
different conditions and incubated with FITC-conjugated antibodies ( ). 
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Chapter Four: Discussion & Conclusion 
4.1 Discussion 
4.1.1 Overview 
The parasitic disease, schistosomiasis caused by the tremetode worm, 
Schistosoma infect worldwide. Infection occurs through the contact of free-swimming 
cercariae with the host's skin surface. The host immune system responses poorly to 
the parasite, the immunopathology of the disease is usually caused by the eggs. In 
order to escape from immune attack, the parasite has evolved different escape 
mechanisms. The parasites may decrease the expression of surface antigens, secret 
immune mediators (Ramaswamy et al., 1995), and even mask itself up with hosts 
antigens, e.g. histocompatibilty complex (Sher et al., 1978; Imase et al., 2004) or 
expression of different stage-specific antigens (Hirata et al., 2005). There are still 
many unknowns about the host-parasite interaction. Currently, praziquantel based 
chemotherapy is used to treat the disease and many preventive measures are employed 
to control the disease, such as education programme and snail control. As 
chemotherapy is not effective and cannot prevent reinfection; scientists are seeking 
other ways, such as the use of attenuated cercariae as vaccine (Hogg et al., 2003; 
McManus, 2004). The WHO has initiated the Schistosome Genome Project in 1994. 
The exploration of the schistosome genome and transcriptome, EST databases (Fung 
et al., 2002) are valuable for studying of schistosome biology, mechanisms for 
immune evasion and vaccine development. 
The cloning and characterization of the anti-inflammatory protein, Sml6 in the 
ES product of Schistosoma mansoni (Rao and Ramaswamy, 2000) and used as 
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anti-inflammatory agent by intradermal gene delivery (Rao et al., 2002) contribute 
greatly on the understanding of host-parasite interaction and anti-inflammatory 
therapy. So, Sjl6 in Schistosoma japonicum, the homologous of Sml6 was 
characterized in this project. The anti-inflammatory activity and immunomodulatory 
activities of Sj 16 were studied. 
4.1.2 Molecular and Structural Analysis of rSjl6 
The cloning of Sjl6 full-length cDNA from the isolated cercariae RNA was 
based on the specific primers designed based on the nucleotide sequence of Sml6 
C D N A (Rao and Ramaswamy, 2000). The cloned Sjl6 full-length cDNA consists of 
354 bp and the translated amino acid sequence has 117 aa. The homology search of 
the nucleotide and translated sequence of Sjl6 with BLAST revealed high 
homologous (100% identity) with Sml6, the Schistosoma mansoni stage specific 
protein (SPO-1) (Valle et al., 1999) and Schistosoma mansoni stathmin-like protein 
(SLP) (Ram et al., 1999). Later, it is shown that SPO-1 and SLP are the same as Sml6 
(Rao and Ramaswamy, 2000). 
The native mature Sml6 that present in the ES extracts of Schistosoma 
mansoni revealed by SDS-PAGE with an apparent molecular mass of 16 kDa. The 
N-terminus transmembrane is hydrophobic and may be the putative signal peptide, it 
is not present in the mature protein. So, it suggests that Sml6 is secreted out (Rao and 
Ramaswamy, 2000).The theoretical isoelectric point and molecular weight of Sjl6 is 
9 02 and 13.7 kDa, respectively. The Signal? program suggested there may be the 
presence of eukaryotic signal peptide sequence and potential cleavage sites. The 
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TMpred program suggested the N-terminus inside with one transmembrane region. So, 
it is strongly believed that Sjl6 is synthesized and secreted out in the skin of the 
infected host, to down-regulate the host inflammatory responses. 
The expression of recombinant Sjl6 using the animal cells expression system is 
unsuccessful, so bacterial expression system was used to express the recombinant 
Sjl6. In the research of Sml6, researchers also encountered the problem of expression 
of the recombinant Sml6 in the mammalian cells system. The researchers were 
suspected that the Sml6 N-terminal leader sequences is not recognized by the 
mammalian cells. So, Sml6 is locally produced and secreted into the immediate 
microenvironment in the transfected cells (Rao et al, 2002). This may also explain 
the undetectable expression of recombinant Sjl6 in the transfected cells. Also, the 
transfection of the recombinant constructs into the mammalian cells may be 
unfavorable. The transfected recombinant plasmid constructs were gradually 
disassociated during the selection process. These may contribute to the unsuccessful 
expression of recombinant Sjl6 in mammalian cells. 
4.1.3 Relationship between Sml6 and Sjl6 
Sml6 is present in the ES product of Schistosoma mansoni. Also, it is strongly 
believed that Sjl6 is a secretory product of Schistosoma japonicum during invasion in 
the skin. The nucleotide sequence of Sjl6 is identical to that of Sml6. 
Schistosoma mansoni is a human parasite, it mainly finds in Africa and the 
intermediate hosts are the snails of the genus Biomphalaria. Schistosoma japonicum is 
also a human parasite, it mainly finds in East Asia and the intermediate hosts are 
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snails of the genera Onocomelania (Rollinson and Rollinson and Southgate, 1987). As 
the geographic distribution of S. mansoni and S. japonicum is different and they have 
different specific snails as intermediate hosts, the contamination of samples between S. 
mansoni and S. japonicum is impossible. 
The genome and transcriptome analysis of S. mansoni and S. japonicum 
proposed that the platyhelminth acoelomates has been diverged from other 
eubilaterian metazoan more than a billion years ago. Schistosome being a parasite, it 
has prolonged association with the hosts and possess specific adaptations to live a 
parasitic way of life, many of the genes that contribute to host immune response 
evasions are highly conserved (Verjovski-Almeida et al, 2003; Hu et al, 2004). The 
identical nucleotide sequence of the anti-inflammatory protein Sml6 and Sjl6 
suggested that this gene is highly conserved along the path of evolution and contribute 
greatly for the success of living a parasitic life for the schistosomes. 
Human infection of schistosomiasis is because of the penetration of the cercariae 
into intact skin. During the course of infection, different immune mediators are 
secreted to protect the parasites from the host's immune attack. Sml6 and Sjl6 are 
secreted when the parasites penetrate into the host's skin. So, it is not surprised that 
Sml6 is identical to Sjl6 and the high conservancy of the anti-inflammatory protein. 
4.1.4 Anti-inflammatory Activity of rSj 16 
Inflammation is a physiologic response of the body to stimulations, e.g. 
infections and tissue injury. The inflammatory response involves a series of cytokines 
and cell mediators. The pro-inflammatory cytokines : Interleukin (IL)-l, IL-6, IL-12, 
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TNF-a are important for an appropriate inflammatory response. The inflammatory 
cytokines are secreted by the immune cells, macrophages, activated B and T 
lymphocytes or fiboroblasts (Roye etal., 1998; McKenzie and Fallon, 2003). 
The anti-inflammatory activity of Sjl6 was studied by the inhibitory effect of 
recombinant Sjl6 on thioglycollate induced inflammation in mice and the differential 
expression of cytokines were analyzed semi-quantitatively by RT-PCR. 
Thioglycollate is an effective agent for macrophage recruitment. The 
intraperitoneal injection of thioglycollate, stimulate the inflammatory response in the 
peritoneal cavity and recruit macrophages to the peritoneal cavity (Cailhier et al., 
2005). In the experiment, the mice were first injected with PBS, rSjCaS and rSjl6, 
respecstively and one hour later, thioglycollate was injected to induce inflammation. 
The total PECs, non-adherent cells, adherent cells were counted and compared. By 
one-way ANOVA analysis, the total number of PECs in rSjl6 treated group was 
significantly less than the PBS control group with P-value less than 0.01. This showed 
that rSjl6 can suppress the thioglycollate induced immune recruitment during 
inflammation. The percentage of non-adherent cells in rSjl6 treated group is 
significantly more than the PBS control group with P-value less than 0.01. This 
showed that the PECs of rSjl6 treated mice consisted of higher proportion of 
undifferentiated immune cells, that is rSjl6 can suppress the differentiation of 
immune cells with the stimulation of inflammatory response. The undifferentiated 
lymphocytes are generally non-adherent. Differentiated cells, e.g. macrophages are 
adherent cells. 
The morphology, cell size and granularity of PECs were studied by Hemacolor 
staining and flow cytometry. The PECs in PBS or rSjCaS treated mice stained with 
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lobed nucleus and the cells were larger and densely granular. The PECs in rSjl6 
treated mice stained large central nucleus and the cells were smaller and less granular. 
The study of FSC and SSC of flow cytometry indicate the different population of cells 
by the cell size and granularity. The result showed that the PECs in PBS and rSjCaS 
treated mice had larger proportion of cells were large and had high granularity. 
However, that of rSjl6 treated had smaller proportion of large, granular cells. The 
undifferentiated cells usually are smaller and low granularity. So, rSjl6 could 
suppress the differentiation and recruitment of immune cells to inflammatory site. 
The activation of inflammatory response stimulates different immune reaction, 
such as neutrophil extravasation, lymphocyte extravasation as the increase vascular 
permeability which leads to swelling and redness of the infected area. The recruited 
neutrophils secrete the macrophage inflammatory proteins (MIP)，chemokines that 
attract macrophages to the site of inflammation. Macrophages can activate cells that 
increase phagocytosis and increase release of cytokines (IL-1, IL-6 and TNF-a) that 
contribute to inflammatory response (Murphy and Reiner, 2002; Robinson and 
O'Garra, 2002; Trinchieri, 2003). During inflammation, neutrophils are first arrived at 
the site of inflammation. Neutrophils have multilobed nucleus and large in size. The 
phagocytic system consists of blood circulating monocytes and tissue circulating 
macrophages. During hematopoiesis in bone marrow, granulocyte-monocyte 
progenitor cells differentiate into promonocytes, which leave the bone marrow and 
enter the blood and further differentiate into mature monocytes. Monocytes circulate 
in the bloodstream for about 8 hours, then enlarge and migrate into tissues and 
differentiate into specific tissue macrophages. Macrophages are five to ten folds larger 
than monocytes and contain more organelles. The nucleus of monocytes is single 
lobed, the macrophages have large rounded nucleus. (Szabo et al., 2003) So, the cell 
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population of PECs in rSjl6 treated mice might be the primary cells that not yet 
stimulate to undergo differentiation Those cell population of PECs in PBS or rSjCaS 
treated mice might be the differentiated immune cells. These suggested that rSjl6 
suppress the action of thioglycollate to induce inflammation through macrophage 
recruitment. 
After the peritoneal cells were eluted out, the peritoneal epithelial cells were 
removed and total RNAs were isolated. The differential expression of cytokines was 
analyzed semi-quantitatively by RT-PCR using specific primers for different 
cytokines. In this experiment, the cytokines profiles o f : IL-1 a , IL-1 (3, IL-lra, MCP-5, 
RANTES, M-CSF and Q-fms were studied. IL-la, IL-1 pare pro-inflammatory 
cytokines, they can be secreted to induce inflammatory response. IL-lra (Ruth et al, 
1996) is the antagonist of IL-la, IL-lp by binding to the IL-1 specific receptors 
without eliciting biological response. MCP-5 and RANTES are chemokines which 
induces chemotactic attraction of lymphocytes. M-CSF is the macrophage 
colony-stimulating factor which by its name is capable of stimulating macrophages. 
^.fms is the receptor for M-CSF. There was no detectable expression of IL-1 a , IL-lra, 
c-frns. Expression of IL-lp, MCP-5, M-CSF, RANTES could be detected. 
IL-la and IL-lp are pro-inflammatory cytokines that are secreted by many 
immune cells and they have a wide range of immunological functions, but they 
mainly play an important role in mediating inflammatory response. IL-lra is an 
anti-inflammatory protein, the antagonist of IL-1 (Arend et al, 1998). The expression 
of IL-lra and IL-la are undetectable. There is weak expression of IL-ip in the PBS 
and rSjCaS treated cells and undetectable expression in rSjl6 treated cells. So, this 
suggested that rSjl6 may capable of suppress the production of inflammatory 
cytokines. However, IL-la, IL-1 (3, IL-lra differential expression observed by 
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Ramaswamy et al., 1995 could not be detected in the peritoneal epithelial tissue may 
be due to the variations in the experimental design and models used. For the research 
of Ramaswamy et al., 1995; human kerationocytes and LPS induced inflammatory 
response was applied. Our approach is by the thioglycollate stimulated inflammation 
in mouse. 
The expression of M-CSF could be detected, but the expression was more 
prominent in PBS and rSjCaS treated cells. The expression of c-frns was undetectable. 
M-CSF is macrophage-colony stimulating factor to stimulate the differentiation and 
recruitment of macrophages, c-fms is the receptor for M-CSF. The low level of 
expression for M-CSF in rSjl6 treated cells suggests the suppressive action of rSjl6 
on macrophage recruitment. 
The expression of MCP-5 and RANTES could be detected, but the expression 
was more prominent in PBS and rSjCaS treated cells. MCP-5 and RANTES are 
chemokines that attract immune cells chemotactically. The result suggested rSjl6 
treatment could suppress the inflammatory response by suppressing the recruitment of 
immune cells to the damage site. 
The level of expression for the cytokines studied implied that rSjl6 can suppress 
the thioglycollate induced inflammatory response. 
It is studied that infection of Schistosoma japonicum can down-regulate the 
production ofIL-4 and IL-10 (Trottein et al., 1999; Ramaswamy et al, 2000; Shen et 
al,, 2002). The peritoneal epithelial cells were collected 3 days after thioglycollate 
treatment, the differentiate cytokines expression might be a fast response after 
stimulation and not long lasting, so the differential expression for some cytokines may 
not be able to detect. Also, the activation of inflammatory response is a complex 
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response, different immune cells and cytokines are activated under different 
stimulation. The cytokines studied might not hit the cytokines that under activation. 
Also, minute amount of cytokines is capable of inducing biological response, the 
cytokine expression may be so low that could not be detect. 
4.1.5 Immunogenicity and Antigenicity of rSjl6 
Immunogenicity is the capability of a substance to induce an immune response, 
that substance is called immunogen. Antigenicity is the capacity to combine 
specifically with antibodies or T-cell receptor/MHC, the substance is called antigen. 
All immunogens are antigens, however, not all antigens are immunogens. 
The antigenicity of rSjl6 was studied by the recognition of rSjl6 by the 
uninfected rabbit serum, the natural Schistosoma japonicum cercariae infected rabbit 
serum or the UV irradiated Schistosoma japonicum cercariae infected rabbit serum. 
The result showed that rSjl6 could only be recognized by the natural Schistosoma 
japonicum cercariae infected rabbit serum, not the UV irradiated Schistosoma 
japonicum cercariae infected rabbit serum. The UV irradiated Schistosoma japonicum 
was attenuated, the protein expression of the parasite was impaired. This might 
suggested that Sjl6 is only secreted by the live infection of Schistosoma japonicum 
not the attenuated. The attenuated Schistosoma japonicum might be incapable to 
express Sjl6. So, Sjl6 are capable of raising anti-bodies that bind specifically against 
it, Sjl6 is antigenic. The live infection of Schistosoma japonicum elicits little or no 
inflammatory response upon infection with the production of the anti-inflammatory 
protein, Sjl6. The infection of UV irradiated Schistosoma japonicum elicit strong 
137 
immune response, this might because it is not capable of producing the 
anti-inflammatory protein, Sjl6. Also, the immunoblot analysis of the recombinant 
Sjl6 with the natural Schistosoma japonicum cercariae infected rabbit serum 
suggested that the recombinant protein may have similar epitopes as the naturally 
expressed Sjl6 during parasite infection. 
The immunogenicity of rSjl6 was studied by the recognition of rSjl6 by the 
anti-serum raised by immunization of mice with the rSjl6. The rSjl6 could be 
recognized by the immunized mouse serum, not the unimmunized serum. rSjl6 is 
immunogenic, it can induce the immune response of the mice to produce anti-bodies 
against the recombinant protein. 
4.1.6 Inhibitory Effect of rSjl6 on rMuIFN-a4 Induced 
Up-regulation of MHC (I) Expression 
Interferon (IFN)-a plays an important role in the first line defense against 
pathogens; and can up-regulate MHC (I) expression and activate NK cells. 
Macrophages, monocytes and fibroblasts are capable of synthesizing IFN-a. 
The major histocompatibilty complex (MHC) is important in intercellular 
recognition and in the development of both humoral and cell-mediated immune 
responses. The MHC molecules act as antigen-presenting structure. MHC molecules 
have 2 forms : class I and class II, both are membrane-bound glycoproteins. MHC (I) 
can bind to a diverse spectrum of endogenous peptides and present them to CD8+ T 
cells. MHC (II) presents the exogenous peptides to CD4+ T cells. As MHC plays a 
major role in immune response, the action of rSjl6 on MHC (I) expression was 
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studied by the effect on rMuIFN-a4 up-regulated MHC (I) expression. The result 
showed that that rSjl6 has an inhibitory effect on the rMuIFN-a4 up-regulated MHC 
(I) expression. 
The MHC (I) molecules are expressed almost every type of cells. The differential 
expression of MHC (I) is under tight regulation mechanisms. It can be regulated by 
promoter motifs and transcription factors; various cytokines or reduction in 
components that need for peptide transport (Sharon, 1998). The inhibitory effect of 
rSjl6 on MHC (I) expression is very important for the immune evasion of the 
parasites. Down-regulating the MHC (I) expression can reduce the presentation of the 
schistosome peptides by MHC (I), thus reduce the host-parasite interaction, the 
parasite can effectively protected against the immune attack of the host. So, the 
inhibitory effect of rSjl6 on MHC (I) expression has great contribution on the 
immune evasion of the parasite by the innate immune response. 
Little was known about the signaling pathway of rMuIFN-a4 up-regulated MHC 
(I) expression. The three signal transduction inhibitors studied : PD169316，PD98059 
and SB203580 (Trottein et al., 1999a; Goh et al., 1999; Ishida et al., 2004) had no 
inhibition effect on rMuIFN-a4 stimulated up-regulation of MHC (I) expression So, 
the signaling pathway of the inhibitory effect of rSjl6 could not be further at this 
stage, due to lack on knowledge on signaling pathways. 
4.1.7 Relationship between Sjl6 and the Innate Immune 
System 
The innate immune system is not specific to any particular pathogens. It is the 
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first guard of the body to fight against invaders. The phagocytic cells, such as 
macrophages play an important role in innate immunity. The phagocytic cells 
internalize and break down the foreign antigens and present the fragments to other 
immune cells in the adaptive immune system. So, it links the innate immunity with 
the adaptive immunity. The innate and adaptive immunity do not operate in total 
independence of each other, they cooperate to produce a more effective immunity. 
The tissue damage during the penetration of parasites into the intact skin induces 
a complex sequence of inflammatory response by the innate immunity. The 
consequences of inflammation are the influx of phagocytes to the infection site and 
also the production of different immune mediators by the immune cells in order to 
trigger a fast response to combat the invader. IFN-a is the important cytokine that 
induce the innate responses and bridge the innate and adaptive immune system. So, 
the suppressive effect of rSjl6 on IFN-a up-regulated MHC (I) molecule expression 
and , the suppressive effect of rSjl6 on thioglycollate induced macrophage 
recruitment may aid the parasites to escape from the immune attack of the innate and 
adaptive immune system. So, rSjl6 may suppress the innate im画ne response and 
thus preventing the further triggering of the adaptive immunity. 
4.1.8 Further Study and Significance 
Based on this project's result, further experiments might be done to analyze the 
interaction site of Sjl6 with its receptor. With the understanding of the molecular 
structures of Sjl6 and its receptor may pave the road for the discovery of an 
alternative method for anti-inflammatory therapy. Also, the inhibitory effect on 
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macrophage recruitment is valuable for anti-inflammatory research. Effective 
anti-inflammatory therapy is in urgent need as inflammation related diseases affect 
millions of patients over the world (James et al., 1983; Proudfoot, 2004). Also, 
characterization of immunological function of Sjl6, provides cue for the 
understanding of the underlying host-parasite interacting mechanisms to discover how 
the anti-inflammatory protein interacts with the host to evade the immune system in 
Schistosoma sp.. In long term, this research provides valuable information for the 
study and treatment for the disease, Schistosomiasis. 
4.2 Conclusion 
The Sjl6 full-length cDNA cloned consists of 354bp and the translated amino 
acid sequence has 117aa. Sjl6 believes to be secretory with the presence of signal 
peptide at the N-terminus. The recombinant Sjl6 is proved to be immunogenic and 
antigenic. The recombinant Sjl6 has anti-inflammatory function, it has inhibitory 
effect on thioglycollate induces inflammation in balb/c mice as the recombinant Sjl6 
suppress the thioglycollate stimulated macrophage recruitment in balb/c peritoneal 
cells. The immunosuppressive function of recombinant Sjl6 was demonstrated by its 
inhibitory effect on rMuIFN-a4 induced up-regulation of MHC (I) expression on JCS 
cell surface, this could suppress the presentation of antigens by the MHC (I) 
molecules to other immune cells. 
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